Podcasts about folks

The International Pain Foundation  Barby Ingle pt 2 I have a very important topic for you today…and one that is very near and close to my heart…one which affects me as well as millions of people each and every day – and that is how to cope with chronic pain…be it from injury, as in my case, or from hereditary diseases or any number of a myriad of causes…one which many people have a hard time understanding – even very close family members… On the line with us today is Barby Ingle from http://www.internationalpain.org/ (the International Pain Foundation)…Barby is a former model and professional cheerleader. She seemed to have it all. And then things changed. Her life become totally focused on survival. Chronic pain ravaged her body. Doctors had no clue as to why. They stuck, prodded, probed and examined numerous times. All sorts of test (and can I relate to that). Then, one day, Barby decided enough was enough and SHE became her own “Chief of Staff” for her medical team.  And I will let her explain that as we get into the interview. Barby has been on our program a few times in the past and the information she shares blessed so many of our listeners, I'm sure it will do the same today as well.  She is also the author of several books dealing with this issue, such as https://amzn.to/3spAEiY (“From Wheels to Heals,”) which is the first one I read, getting ready for our first interview back in 2018! Praise God! This is part two of what turned out to be a great, two part interview! Your foundation helps people from all over the world find support services and resources to help their conditions. Can you go over a few of the most popular services? This next topic is a big one. What about managing pain killers? I know the laws and medical practices concerning prescription pain killers have changed since the last time we talked. Is it still a major issue? Pastor Bob shares about kicking his addiction to pain killers after talking with Barby Ingle and reading information from thehttp://www.internationalpain.org/ ( International Pain Foundation website…) This is the type of situation where your foundation could provide the resources to help someone in a situation similar to what I went through (and, I was reading articles, etc. from your website while going this ordeal myself). Barby, you've outlined a lot of this in your book, https://amzn.to/3spAEiY (“From Wheels to Heals,”) correct? Pastor Bob shares on how he continued to be the “Chief Medical Officer of his own body.” Barby, it's amazing what you can do when you make up your own mind, put your foot down and tell the doctor that “this is the way it is going to be.” Barby, if something we said sparked a word of enlightenment to one of our listeners and they had an “ah-ha” moment saying, “That's just like me!”  How can they get in touch with thehttp://www.internationalpain.org/ (International Pain Foundation?) If someone wanted to get in touch with you, maybe to ask a question or do an interview such as this, how can they do that? How can someone get in touch with you? Folks, pain is real. Pain is, well, painful. Some people do well bearing with pain. Some pain is the result of an injury and can be fixed. But there are times when pain is present and nobody knows why. We are talking about physical pain here. But that physical pain can definitely become psychological pain very quickly. You cannot deal with this yourself. http://www.internationalpain.org/ (International Pain Foundation) is here to help you. They will provide you with the resources to learn more about your conditions. They will provide you with the resources to get help. They will provide you with the resources to find  someone you can talk with. They are here for you. Barby Ingle founded this great organization because these resources were not in one centralized...

See omnystudio.com/listener for privacy information.

This week on Toilet Radio: We're talking about INFLATION and I don't mean erotic images online! Classic rock VJs cannot handle the cost of chicken parmesan. Joe cannot justify spending $29 on apples. Inflation is so bad that Vince Neil is forced to do ads for payday loans. And amid all this, Metallica thinks you'll spend $1600 on a record player? And here comes Universal Music Group gouging the price of vinyl? Get right outta town! We're also talking about Matt Pike's descent from fun, drug-addled weirdo to "Jewish banker" conspiracy mongering. Not great! Finally, we're talking about the imminent return of Power Trip. Folks, it's an episode. Music featured on this ‘sode: Low Cunning – I Refuse to Believe This Multi-Level Dungeon Was Formed Naturally Over Several Eons Because There Are Fucking Stairs Between Floors Don't forget to rate, review, and subscribe to Toilet Radio on iTunes so you'll get new episodes automatically. Or use Stitcher if you don't fuck with Apple.

WEDNESDAY! Folks, despite the tragedy around us we have a great show for you today! We have podcaster Jami King (murderish.com) who hosts MURDERISH and the new podcast Dirty Money Moves: Women in White Collar Crime! You are going to love her. We delve into Bravo and crossover to the intersection of women in white collar crime (which Bravo is no stranger too). Enjoy and stay safe out there. Also, So Bad It's Good has merch now! Go to www.sobaditsgoodmerch.com to order yours TODAY! Also, So Bad It's Good has a voicemail now! 323-425-9542. Pleas feel free to call with your thoughts! If you do you are giving me full permission to use on the show! Also, I'm on CAMEO. I'll be filming in Dorit's Room so sign up today at cameo.com and search Ryan Bailey! Have a great week guys! Remember to subscribe and join me Monday thru Thursday for interviews with podcasters and reality stars, show recaps, Garth and Justin, Bill and Becky Bailey and so much more!! Plus, tell your friends. I, honestly, think there is something for everyone in these pods. The more the merrier!  ALSO GO CHECK OUT THE PATREON patreon.com/sobaditsgood. Support what we are doing here. THANK YOUUUUUUU!!!!! If you're enjoying the insane amount of blood, sweat and literal tears of this pod consider telling a friend or rating us 5 stars on iTunes! Special shoutout to Maritza Lopez (Insta: @maritza.gif) for all of her insanely hard work creating these beautiful pieces of art on my instagram and patreon page!!  Time Stamps are below. Use them. They are your friend. This pod isn't meant to be digested all at once! Contact me on Insta if you need me to send them to you if you can't find them! 3:16-Show Notes/Texas 15:15-Jami Rice Instagram: @sobaditsgoodwithryanbailey, @ryanbailey25 Twitter:@ryanabailey25 TIKTOK @sobaditsgoodwithryanb Learn more about your ad choices. Visit megaphone.fm/adchoices

Folks, we got a special episode for you! Ry, Serene & myself break down Kendricks new album and our takeaways from the deep messages on this album. Part 2 coming soon.  @optfitness optimalaz.com

Folks, Michelle and Scott have returned. They discuss season 2 of "The Fishmonger," new series "Ranch America," high cost of travel, being on TV, Horses vs. ATVs, Michelle tells a sad story, surf scoters, the Salton Sea freakshow, New host of the Sporting Chef, Big Cedar Lodge, Tunaville Market, FloridaBowfishing.com, Lucie Cardet and Michelle speaks French and she's still a wine snob (but she doesn't mean to be). Big Cedar Lodge FloridaBowfishing.com The Fishmonger Dead Meat The Sporting Chef Bullet Proof Communications

Harry's guest this week is Rohit Nambisan, CEO of Lokavant, a company that helps drug developers get a better picture of how their clinical trials are progressing. He explains the need for the company's services with an interesting analogy: these days, Nambisan points out, you can use an app like GrubHub to order a pizza for $20 or $25, and the app will give you a real-time, minute by minute accounting of where the pizza is and when it's going to arrive at your door. But f you're a pharmaceutical company running a clinical trial for a new drug, you can spend anywhere from $3 million to $300 million—and still have absolutely no idea when the trial will finish or whether your drug will turn out to be effective. Because there's little infrastructure for analyzing clinical trial data in midstream or spotting trouble before it arrives, some studies continue long after they should have been canceled, and positive data sometimes gets thrown out because of minor procedural flaws; in the end, 20 to 30 percent of the money drug makers spend on clinical trials goes down the drain, Nambisan says. Lokavant's platform allows drug makers and clinical research organizations to harmonize the results coming in from study sites, compare it to data from other trials, and discover important signals in the data before it's too late. For example, a company might discover that it's not enrolling patients fast enough to complete a trial on schedule, or that the researchers administering the study aren't following the exact protocols laid out in advance. Such headaches might sound abstract and remote, but poor data management slows down the whole drug development process, which means fewer beneficial new drugs make it to market ever year; that's the ultimate problem Lokavant is trying to fix.Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac. 2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings & Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars. 6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner. 8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out. 9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.TranscriptHarry Glorikian: Hello. I'm Harry Glorikian, and this is The Harry Glorikian Show, where we explore how technology is changing everything we know about healthcare.My guest Rohit Nimbasan comes from the worlds of biotech and data science. And during our interview he made an interesting point.These days you can use an app like GrubHub to order a pizza for twenty or twenty-five bucks, and the app will give you a real-time, minute by minute accounting of where the pizza is and when it's going to arrive at your door.But Nimbasan points out that if you're a pharmaceutical company running a clinical trial for a new drug, you can spend anywhere from $3 million to $300 million and still have absolutely no idea when the trial will finish or whether your drug will turn out to be effective.The problem is, there's just no infrastructure for analyzing clinical trial data in midstream or spotting trouble before it arrives.As a result, according to Nimbasan, twenty to thirty percent of the money drug makers spend on clinical trials goes down the drain, because of studies that continue long after they should have been canceled, or good data that gets thrown out because of some minor procedural flaw.Nimbasan is the CEO of a company called Lokavant that wants to change all that.The company is building a data platform that allows drug makers and clinical research organizations to harmonize the results coming in from study sites, compare it to data from other trials, and discover important signals in the data before it's too late.For example, a company might discover that it's not enrolling patients fast enough to complete a trial on schedule, or that the researchers administering the study aren't following the exact protocols laid out in advance.All of those problems can increase the cost of a trial.They can even lead regulators to deny approval for a drug that might have proved effective if it had been property tested.For an average healthcare consumer, these kinds of headaches might sound abstract and remote, like something only clinical trial managers would ever have to worry about. But the fact is poor data management slows down the whole drug development process, which means fewer beneficial new drugs make it to market ever year.So I think we should all be cheering companies like Lokavant who are trying to fix the process.Here's my full interview with Rohit.Harry Glorikian: Rohit, welcome to the show.Rohit Nambisan: Thanks, Harry, for having me.Harry Glorikian: You know, you and I sort of talk off and on all the time about the space and what's going on, but, you know, having it on the show, I have to step back and sort of forget everything I know about the company and start from scratch. So, you know, can you explain to people Lokavant's business in a way that would make sense to someone, say, outside of the pharmaceutical industry. In other words, you know, what are the big problems you're solving for organizations that, say, are running a clinical trial, and how are you solving them?Rohit Nambisan: Sure, I can do that. I think it bears noting that we should probably step back a little bit and talk about the industry as a whole and where it's been going, and then I can clarify where Lokavant comes in. So I think as many folks know and for those who don't, I'll fill in the blanks. I know you know this area, but in the last, I'd say 15 to 20 years, we've been moving in pharmaceutical development away from blockbuster medications, things like diabetes type 2. Right, developing therapies for that and getting each drug developer trying to find a smaller piece of market and larger pie to specialized, niche therapeutic indications. Right. So the way I could probably better started with the diabetes example is it's no longer diabetes type 2. It's let's develop the compounds or therapies for diabetes type 2 patients that are comorbid with that have also chronic kidney disease and are metformin naive, meaning they haven't taken a particular therapy known as metformin. Right. So it's a more complex filter criteria, so to speak. Right. And so what happens when the industry moves in that that direction is that when you get into these very niche therapeutic areas, you need to collect particular niche, commensurately niche types of data to validate your hypothesis whether or not this therapy is safe and efficacious through clinical trials. Right. Rohit Nambisan: And in doing that, you now increased the complexity of the trial greatly, not only in terms of the different types of data collecting, but the amount of different types of data you're collecting. So now each trial becomes a lot more specialized. Not just specialized therapeutics, but each trial becomes more specialized. Right? And so for that reason, we've seen a big challenge as we as we moved across that space. And actually, it's been really beneficial for patients because now we're going after, as an industry, we're going after really niche unmet clinical needs that previously there were no therapies for or being developed for. So it's a really good thing for a patient perspective, but from the perspective of development, it makes it that much harder. Not only is there a smaller market opportunity, there's less patients to treat, right, but the complexity, the actual costs of the trial and the complexity of trial has gotten exponentially that much greater. So what Lokavant came out of was we were actually a, shall we say, an internal initiative within Roivant Sciences, which is a company that launches a number of different biotechnology companies and tech companies as well. But better known for biotechnology companies. And we saw a great need to be able to develop therapies for niche indications much faster, much more efficient, much more cost effectively, and also meet the complexities of that trial better through novel data and tech.Rohit Nambisan: And so what Lokavant is essentially, is a data platform that allows drug developers, pharma, therapy developers, to be able to choose which data sources they need, data types they need for a trial. And we can ingest any of those data sources, we can analyze any of those data sources in a holistic manner and expose patterns or signals that could be beneficial or detrimental to the study on an ongoing basis. And when I say ongoing basis, I mean you're not waiting until the end of the study. And I guess the best way I can align this is just like my kids do sometimes. You're not waiting until the last day before your term paper is due, before the project's due to finish your work, you're actually assessing, doing bits of it along the way to assess where there may be challenges, which gives you, really, the time to correct issues to manage your trial better. And frankly, each one of these trials now, there are between, what, $2 million and $300 million we're investing in these single trials at this point. So it's egregious to me that we do not have the toolset to be able to even identify, pull in that data effectively on an ongoing basis to detect these signals so we can plan effectively to do something about it.Harry Glorikian: Anybody who's done a clinical trial knows that there's a lot of risk. Right. So, you know, can you talk about some of the types of risks you're trying to help make sure drug developers diminish, for the most part.Rohit Nambisan: Yeah. So I think the way we start with that is always at the highest level, time, cost and quality, right? So when we talk about time, it's really important to understand that you're going to be able to achieve less. For example, I'll give you a few instances. Target participant accrual, right? Obviously for you to run a trial effectively, you need to have particular types of participants or patients, if it's a sick population. In a vaccine population, they weren't necessarily sick. So that's why I use participants as the term. But you need to make sure that you have path to randomized screening and randomizing these patients for your trial in a given time period. Right. And if that's if your enrollment is is not on track for the countries and the sites you've decided to actually activate the study in, you could, your timeline for your study could be exceptionally extended. Right. So that's that's one type of one example of a thing we look at to understand how the timeline looking for the study. Another area on timeline for example and similarly is discontinuation. So you can you could enroll patients fine. But if you've high volumes of discontinuation of participants in your study, then what ends up happening is you actually don't have as many evaluable subjects in your study of some evaluable participants. So you have to recruit or enroll more subjects, right? So that could extend the timeline as well. One aspect of the timeline that really affects the overall market opportunity is oftentimes these therapies are only in under patient for a certain amount of time. So the faster you can get them to market, the faster you can get recoup your return on investment. But also on the patient side, the faster we can get these therapies out through the market to address unmet clinical needs. That's just one flavor.Rohit Nambisan: Then we have subsequent types of flavors. When we talk about data quality, making sure the data is actually collected in the way that you stated you wanted it to be collected in the plan and the protocol at the outset of the study, as well as cost implications. Right. So we look at cost implications as well, which is how, what will this, what will the extension of enrollment or bad data quality data do to the overall budget that you had planned for this study? But then when you drill down on the level further, you can get into risk categories, is something we look at quite a bit when we look at things like protocol, adherence, when you're when you're collecting this data, as I mentioned, it has to be done per a very prescriptive method that is specified a priori before starting the trial in a protocol. And if it's not collected in that manner, it can be discounted. So we are tracking the risk to protocol deviations and understanding trends and not only understanding trends within that study, but we're looking at similar types of studies in this particular therapy area, neurology or say, psychiatry or gastrointestinal type studies and saying, what has been the protocol adherence in studies like yours? And therefore, can we glean some insights about how you are doing in your study based on your comparators in the study as well? But that's just a small flavor. I could probably wax on for quite some time on this question.Harry Glorikian: Well, that that brings us to the question -- I mean, everything you just said, it brings to the question like, from what I know, the company sort of predicts how clinical trials will go by comparing it against a proprietary data set of, I think I was reading, 2000 past trials, right? So I guess the question becomes, so you're comparing one to the past of things that are similar, but you know, for everybody who's listening sort of, you know, where does that data come from in one sense, is it truly proprietary? I mean, that's what I'm you know, that's my set of questions at the moment.Rohit Nambisan: Sure. So I worked for a while, before coming to the life sciences, in the R&D space and the life sciences commercial space. And I think that data sets, are there are proprietary datasets in that space? Very much so. But there is a third party market for that data a little bit more. So then we find life sciences data. It's really hard to get access to R&D data and as you can imagine, that makes a lot of sense, right? If you're a drug developer or a pharmaceutical developer that successfully completed a trial, you never want to share that data. Thereafter, you spent millions of dollars investing in the study, if you want. If there are potentially unknown issues that you haven't identified, would you want to put that at risk? If you are similarly, if you are a therapeutics developer that didn't meet your endpoints, do you want that information to get out and maybe potentially things that issues that that you should have should not overlook, right, getting out in public, etc.? There's just a lot of business risk. There's also IP risk, right? There's a number of different risks associated with getting that data out. So it's been not a very straightforward journey to aggregate data in life sciences, R&D. That being said, I think how we approached this was we've developed models that are both used for benchmarking, as I mentioned before, comparing against similar trials for particular performance KPIs, so to speak, as well as predictive model generation and machine learning models that require a fair amount of data to train on to actually deliver value.Rohit Nambisan: And in that model, we've talked to a lot of our partners or let's say folks that leads them before their partners. And we talk to them. We say we have a growing dataset. There's precedent for this because we've done this with other partners, number one. Number two, we've worked with them to leverage their data combined with our data, write their enterprise data with our data, because it's a common, it's not just one entity's data that's going to provide that value. Your performance, your processes, the way you run trials is inherent in your data. And if we don't leverage that data to train our model to retrain some parts of our models against, we're not providing you the most value we could be with our predictive models or benchmarking. So with that approach, we've been able to do comparative analysis of our data set versus other people's datasets and then anonymize their data upon having a partnership with them to grow our data assets in a very risk-tolerant manner. Right. All the information about CROs or sponsors or other entities, people running trials is removed from the data and we only leverage that data for the purposes of analytics or generating a benchmark. So none of that data is ever shared. So through that process, over the last, I'd say two years, maybe a little two years and change since we started, we've been able to continuously grow this asset and provide greater and greater value with our descriptive diagnostic predictive analytics as well as our benchmarking.Harry Glorikian: How much money, if you had to guess just to give people like an idea, how much money do you think gets poured down the drain preventably every year, and you could save all this money if you just ran smarter, if you did smarter clinical trial management, if I had to frame it that way.Rohit Nambisan: Oh, at least I would say we've done some back calculations on this and happy to digress into the details of them if warranted, but at least somewhere between 20 to 30 percent of the trial costs right now and depending on the phase and depending on the therapeutic area, again, that could be anywhere from 20 to 30 percent of $3 million to $300 million per study.Harry Glorikian: Yeah. I mean it's you know, that's got to be, I don't know how many billions that is. I can't I don't know exactly how much is being spent annually off the top of my head.Rohit Nambisan: We believe we've done some back of the envelope calculations to show that it is in the billions for sure. Across the across the global pharmaceutical market, we're looking just just the value proposition and the signal detection we're bringing to bear is somewhere around $18 to $20 billion, in terms of market opportunity.Harry Glorikian: I mean, how would you guys run or help a team run a clinical trial in practice? Can you sort of give me a real-world example, maybe de-identified, where you helped the client avoid or mitigate some kind of risk, whether it has to do with patient enrollment or site compliance or safety issues during a trial, any one of those will do.Rohit Nambisan: Sure. So I think one example that I can bring to bear is working with a large CRO. And with this large CRO, they had a sizable data asset that was not harmonized, so to speak. It was still living in the transactional exports from the source data systems or CSPs. Et cetera. All around. So it was they had a bunch of different hypotheses about where they were proficient, where they were deficient, but nothing validated. So we spent some time with them trying to understand what all their data assets looked like. And we started collecting these different representations of former trials and ongoing trials, and we collected them and we harmonized them. In fact, as I mentioned before, one of our major differentiators is this is creation of a single source of truth. And we take that upon ourselves, too. It's not like a service, it's part of our offering, right? Our platform offering. And so what we did was we brought that data together and we it was about, I think 400 to 500 studies worth of data at that point. We harmonized it into what we call our local and canonical data format, which is a single representation for multiple different domains of data, scientific data, operational data, enrollment data, etc. And then we compared that against similar studies in our repository, our growing repository, and said, okay, we can tell you comparatively that you are deficient in these particular areas and you're very proficient at the various--for example, in this case they were very proficient in achieving first patient in on the timeline that they expected to actually, scratch that, that they were very they were very proficient in actually accruing the subjects by last patient in in the time they were expected to write so they could hit their accrual when they wanted to.Rohit Nambisan: But when we looked deeper into the data and looked at across like first patient in, the 50 percent enrollment mark for the study and then last patient in for the study, we were able to identify that there was actually a slowdown and a major overcorrection to make up for that. So they were actually hitting what they needed to hit. But as we all probably know, at least in the clinical research phase and any or any budgeting process, being over your budgeting process is bad. Being under your budgeting process is bad, right? So in this case, it's again the same. They were burning resource and cash and resources to rapidly overcorrect for for a milestone they were not hitting reliably earlier in their studies. And so we realized in that accrual situation we said, okay, what you need is, we've identified an error, you're potentially deficient. What you need is an enrollment forecasting application that brings in the data in real time from your study. Right. And it also combines historical data from our repository in your historical data to seed some prior knowledge about the study. So and it's automated, fully automated. So every day you can understand where you are in relation to where you need to be. Right? And it's not a naive straight line kind of curve. It's basically it's based on looking at thousands of historical studies in this space and understanding what the curvature of the actual model should look like.Rohit Nambisan: So we generated that and we were able to actually, in the proof of concept, and this is just one particular example of an application we've been able to generate from our clinical trial intelligence platform, we generated that and we were able to, on a study, predict two years out within one month when they would actually really hit the accrual and it was within one month accurate. Now while that was valuable in terms of understanding at the end state, what really the value was of this closed loop model, so to speak, right, is that it is closed loop. It allows them in silica to say, what happens if I open some sites here? What happens if I close some sites? So what happens if I close this country here? How will that affect my plan before I put that into action in the real world, which oftentimes is very, very, first of all, it's very risky. But second of all, it can yield a number of unknown consequences if you don't try it before in silico. So I think the approach here was we were able to not only predict these things better and also predict the impact of change orders on the study, that might actually affect the timeline of the study. But we were able to actually provide them an application, an interface by which they could test it all their hypotheses in a virtualized manner before they implemented them. And we're growing like crazy with that, with that partner right now at that point.Harry Glorikian: Yeah. And I mean, I mean, you know, in some ways it sounds like, you know, I didn't get it done and I'm pulling all nighters, like at some point so that I can get it done. Right. So there's a whole staffing model. And how do you bring this to the attention of everybody so that they don't drop the ball? Right, because there's a million other things that might be coming at them at that moment.Rohit Nambisan: That's exactly right. Actually, one thing I'll add to that, given you mentioned the staffing model around it, is that we were born within small biotech. Right. And small biotech is very resource-constrained in its ability to manage and oversee a study. That's fairly well known. So our approach has always been what I'd like to call machine-assisted human intelligence. We have experts that are human experts that know the space, but they need to be augmented. They need to be able to look at more complex streams of information and have a machine pick out particular salient insights, salient information, and provide that to them so they can process it, reducing degrees of freedom for them to process it.Harry Glorikian: So just I mean, there are a lot of statistical tools out there now that that for managing risks in clinical trials. So how is the approach that you guys are taking either different or better or both.Rohit Nambisan: It's a good question. One way we've been able to address this question is that statistical approaches generally require certain amounts of data points to be collected before you can warrant using statistical parameters or assumptions, etc. And so there's two things at play here. On top of that, I just mentioned, we're moving into more specialized therapeutic areas, right? So patients per study are smaller, right. And on top of that, when you're starting out a study which is usually the riskiest points in the study, when you're early in the study to mid-stage in a study, you cross them with the fact that you have less patients and there are more niche studies, it's hard to find those patients. Now, your early phase, your riskiest phase, is going to be extended as compared to when you were developing against blockbuster indications. So for a long time in the study, you can't really reliably use statistical parameters to identify an outlier or identify something as aberrant. And then you need to focus on so the way we've done it, we've done it in a slightly different way. There's two approaches. One is we've actually developed a pretty complex risk score system that's based on a set of very different metrics. Think of it as like an array of different KPIs, right? Those KPIs will affect risk differently depending on the type of study you're in. And they'll have different weights to those risks of time, cost and quality depending on the study you're in. So we look at the given study, we're going to deploy and we say, okay, what are the features that characterize the study? Let's look in our historical repository against those same features, pull similar, we call look alike studies and we'll understand how to set those weightings to say protocol deviations at this point in the study are going to impact the overall quality of time. That's much more for this type of study. So we can basically, for lack of a better term, I guess the simplistic way of saying is we can augment the data that we have coming in from a study, which is small at the outset of the study, with lookalike data to increase the power. Right? So that's another way to look at this. So we can actually, we have much better power to be able to detect these issues earlier on and reliably confer that to clinical operators and clinical developers who can do something about it.Harry Glorikian: It would be nice if you had enough data at some point to almost run the whole trial in silico, in a sense. But I think we need a lot more data get there. But, just for everybody that's listening, sort of as a philosophical point, the reason we put drugs through clinical trials in humans is we simply don't know whether they'll work or what the unexpected side effect they might have once you start them on a much larger population. So in that sense, it's expected, even normal for some drugs, maybe even a lot of drugs, to fail at some point in phase one, phase two or phase three. And as an investor, you know, you don't want it to fail in phase three. You want it to fail early. So is Lokavant's goal to reduce the failures or simply help drug developers get to yes or no faster, safer, more cheaply?Rohit Nambisan: Yeah. So our approach has been initially get yes or no faster, safer, more cheaply, more efficiently, right. As part of that process and actually related to some of the work we have done in the last few months on monitoring scientific risk. Right. You have to be careful about these efficacy analyses because they can unblind the study, especially when you have single or double blind blinded studies. So you have to be careful about this point. But in some circumstances we can actually leverage our analysis on blinded endpoint analysis and understand how particular endpoints are collaborating or not collaborating or trending, to understand if there is any effect whatsoever that's being generated in the study. So this is early days for us. But to your to your point about the first use case, we are starting to think about that as an opportunity as well, because we found a way to effectively blind the information and still assess the information content to understand if there is any form of efficacy signal being produced. So I think that that is a really valuable way for us to approach the market in the near future. I think the other point here is that if you are cleaning the data, if you are identifying those data quality issues on a more real time basis, you should be able to reduce the time to do an interim analysis. Right. We should be able to -- you mentioned fail fast. Right. Failing fast requires you to also assess the data, to understand if there's an efficacy signal, there's a safety issue. And if we have these long cycle times before we can actually do an interim analysis. And much of the data indicates that those long cycle times are due to not knowing where the issues are and finding those issues then cleansing them. If we can do that faster, we should be able to do interim analysis much more frequently. Therefore, being able to generate a fail fast scenario.Harry Glorikian: You could almost, you should be able to set up the system to almost be running it and sort of move the bar on where it is on, “Looks successful,” or “It's moving down towards failure.” There's got to be some sort of almost real-time indicator as data is coming in to. You just don't want humans to jump the gun on that. The interesting thing is, I was looking at one of the blogs you have and you sort of say that one of the main reasons clinical trials are so costly and inefficient is bad data management and a lack of interoperability across data repositories. And, you know, it's funny because anybody who listens to this show knows that just comes up over. And it doesn't matter who you are in health care. It is a recurrent theme that for some reason people are not willing to step up and solve. I mean, it has to be a party like yours that comes in and helps clean it up from the outside as opposed to it being cleaned from the inside the way that you would ideally like it to be.[musical interlude]Harry Glorikian: Let's pause the conversation for a minute to talk about one small but important thing you can do, to help keep the podcast going. And that's leave a rating and a review for the show on Apple Podcasts.All you have to do is open the Apple Podcasts app on your smartphone, search for The Harry Glorikian Show, and scroll down to the Ratings & Reviews section. Tap the stars to rate the show, and then tap the link that says Write a Review to leave your comments. It'll only take a minute, but you'll be doing a lot to help other listeners discover the show.And one more thing. If you like the interviews we do here on the show I know you'll like my new book, The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer.It's a friendly and accessible tour of all the ways today's information technologies are helping us diagnose diseases faster, treat them more precisely, and create personalized diet and exercise programs to prevent them in the first place.The book is now available in print and ebook formats. Just go to Amazon or Barnes & Noble and search for The Future You by Harry Glorikian.And now, back to the show.[musical interlude]Harry Glorikian: So on this show we talk about, you know, how does analytics play into this? So, how do—and I've got to start finding new words—but AI and ML come into this picture. What types of tools in the AI toolbox is Lokavant using? What special powers does AI give you to extract predictions from your data set that other people don't?Rohit Nambisan: Yeah, I think I think the first piece is, and it's going to sound interesting in relation to what folks usually talk about in terms of AI and ML, but it's a harmonized data model, right? When I was working as a data scientist a number of years back, nobody told me all the work that you have to do with data governance and data harmonization. And then when you think about fast forward today where a lot of the actual models themselves are function calls, right? You realize that a lot of the work is actually making sure that data is ready to be analyzed for this particular use case. Right. So it's not to say that we don't do a number of different, try different approaches to gradient boosted descent or support vector machines or neural nets, which is actually my background in terms of grad school and research. But we spend a lot of time thinking through how we need to harmonize, create validated data pipelines to harmonize data for use. In this case. And even in that case, a lot of the work we do is a kind of intelligence or artificial intelligence. So when we're harmonizing the data, we're looking for views on leveraging multivariate clustering algorithms to actually figure out which particular types of data attributes should be mapped to one particular field.Rohit Nambisan: So it's not to say that the data harmonization is devoid of intelligent approaches, it is full of intelligent approaches, but it is an absolute necessity to have the integrity of the data that you need to run those sophisticated front end models, which we run a ton of. But I just I want to call attention to the fact that that is a core asset for Lokavant from the get-go, that Lokavant's canonical data model and the processes we use to harmonize data to get it into that state has been a core focus because if you can do that—and that is the same model you're providing to your data science and analytics teams, your product development teams—then you really have that flywheel that you can generate a number of different analyses. For example, I just mentioned that predictive enrollment forecast model that comes off of in our our Lokavant canonical data model. That is something that is a predictive model, leveraging historical data and ongoing study data in an automated model that indexes towards the historical data early in the trial, indexes towards prediction indexes towards ongoing study data as it comes in. And we have more confidence that input over the trial, that's like an emergent benefit of having the harmonized data harmonize.Harry Glorikian: So, you know, one has to ask in the age of the coronavirus, right, how has the business of running clinical trials changed since the pandemic? I mean. And how do you guys...is that an advantage or disadvantage? I'm trying to, you know, place where you guys are in the whole realm of how things have hopefully changed for the better.Rohit Nambisan: Yeah, it's been quite a tailwind for us actually. And I would say that, number one, it's been it's been beneficial to us because there's just been a lot more scrutiny and interest in clinical research. Not to say there wasn't before, especially for niche therapeutic areas, but and the fact that we were able to develop and get novel COVID vaccines out pretty rapidly. But there was also a lot of challenges along the way in getting to that point. And also delays and trials and challenges in therapeutics development to address COVID as well. So there's just been a lot of scrutiny in the last 24 to 30 months on how efficient and how fast and how effective clinical research can be. So just that alone has been beneficial. Now let's take the next step there and say that all associated with the pandemic, there's been a great impact to clinical trials across the board, not just COVID trials or therapeutic trials. Patients, participants couldn't get to sites for site data collection, right. Site staff couldn't get in there, too, for data entry or site management or site oversight activities. Right. So in general, it's been a huge boon to those technology groups that have developed, decentralized or direct-to-patient data capture methodologies, thereby lowering the patient burden and the site burden for clinical trials to continue in a pandemic fueled environment. What's interesting about that as well, when we think about ourselves as both a data type agnostic platform for clinical research as well as an analytics engine, a platform on top of that, you see this huge movement to another type of data, another data, for example, decentralized trial data as another data source.Rohit Nambisan: And what we've seen also is that while there's been a shift to a lot of decentralized trial collection on most studies, at least 90 percent of studies and above, they're hybrid, they're not fully decentralized. So you have to have some site data collection and you have some decentralized data collection. And that makes sense for those things that may make the most sense to lower patient and site burden to administer. Let the patient let the participant be at home. For those that require like biopsies, etc., that require a participant oftentimes to come into the site, let that be the site. The challenge there is now you have these two different complex data streams that are not necessarily harmonized and aggregated. So this is, again, I think that's been an area where we've been able to come in and say we'll just as a matter of course, you're doing business, this is another data set to us. We need to bring these two in and we have to also enable comparative analysis against decentralized and traditional site based data collection, because otherwise you're going to miss insights. You're going to miss information that are critical to your study.Harry Glorikian: Yeah, a part of me was just thinking, you know, you guys should buy somebody, like Unlearn AI and go at it together where you can have, you know virtualized patients that you can put into the trial, but that's… we won't go there. So let's step back for though, for a second. So let's talk about the company's origin story. Lokavant is one of many companies launch by Roivant, as you mentioned earlier. A Lot of the companies end up with the word “vant.” So can you explain so that people understand: What is Roivant, how it operates, what are vants and and why was Lokavant born. And how did you become president and CEO?Rohit Nambisan: Sure. So Roivant started about seven years ago. And I should mention Roivant is our parent company. We were founded out of Roivant and spun out as a technology company itself. So Roivant initially started as a company that launched "vants" -- nimble, entrepreneurial biotech companies and now health tech companies as well. When I joined Roivant three and a half years ago, Roivant had about 15 different biotech companies. And what was really interesting about their approach is it was therapy agnostic, so it was not that there was a strategic focus or oncology or strategic focus on immunology. There was a focus around identifying compounds that may have been deprioritized in larger pharma companies, which says pharma companies that had a lot of potential and had could address critically unmet clinical needs. And so Roivant would in-license those therapies and start a therapy therapeutically oriented vant. So at the time Axavant it was the new neurological oriented, neurological disease oriented vant. Myovant was the human reproductive oriented, disease oriented vant. Et Cetera. And so now when you think about somebody like myself who comes from the tech world and life sciences, health care technology world, brought into Roivant three and a half years ago, the premise behind Roivant at the time was we can more efficiently develop these therapeutics and have more favorable outcomes leveraging innovative ways of addressing human talent as well as technology. And that latter piece is where obviously I came in and we were starting to look at in my team what are some of the most significant challenges and frequent challenges amongst the vants themselves in running these clinical trials? And then does that map against some of the more significant frequent challenges we see outside in the market? And not surprisingly, there were quite a few particular areas of resonance.Rohit Nambisan: At that point in time, they're about 54, 45 programs being run by Roivant. And so it was across a variety of therapeutic areas. And I guess the thing that hit us in the face primarily was I guess the best way I could say it is you can order a pizza, right? You can understand what is it, a $25 investment, $20 investment. Maybe it's gone up since then, since I ordered a pizza. But the point is that you can understand what time it was ordered, when it was when they said they were going to deliver it to you, and you can track it. And most of these apps now [show it] along its destination to a chain of custody to get to you. We were we could spend $3 to $50 million on any given trial and we were at struggling with our partners to actually identify what is the current state of enrollment in the last week? What is the current state of discontinuation? Where are we at with our with these particular sites in this region? Why are we seeing high screen failure rates, etc.? Right. That's egregious to me. That's just that should not be the case.Rohit Nambisan: We are fairly frustrated with that. And then even when we when even at Roivant or even in my former experiences at Novartis or other pharma, when we brought in a source system to say, okay, well, we're going to have a representation of data ourselves, right? So that we can understand what's going on. Invariably what happened is you would have one source system here and then a duplicate version of that sort of system at the CRO or another vendor that's working with you. You spent your entire time trying to figure out which was the source of truth, because they're spending all your time doing data reconciliation, saying, is that really accurate? Is that really the signal? So that didn't work either. So we felt pretty frustrated about this. We initially tried not to build it ourselves. We worked with a few different collaborators outside of Roivant and tech vendors, etc., and we were fairly frustrated with what we came back with there. So at that point we started thinking, if we can't buy it, we need to take a lead user innovation approach to address this. So we started out with the data platform, as I mentioned to you, and we built that capability to connect, ingest and map from any source, deliver that within a canonical data model, one single canonical data model. And then initially we did a bunch of bespoke analysis on top of that for a few different biotech vants. Rohit Nambisan: That went really well. Some of the external collaborators looked to Roivant at that point we said we'd like to work with this technology outside of the Roivant family, and we realized we were on to something, and we externally launched the company in January of 2020, which was very interesting time and year to launch a company. That being said, we spent the first, I'd say, just under two years, really focused on externally subsidized R&D phase. We're pretty fortunate to have some partners that invested in us in that phase, and we focused on first one particular application in response and we talked a lot about risk. But then we also realized that the needs across different companies, different vendors, etc. for managing clinical trials are very varied. So we realized what we need to really build as generalized on that first application we built and create a highly configurable analytics platform on top of this data platform so that we could actually analyze many different things and configure it for use for any particular customer. And so now we built across, I'd say seven or six or seven different use cases now, and we've deployed most of them and we're continuing to aggregate information in a true product sense where the biggest pain points in the market and how do we build or configure a version of the platform and the platform to address that. And at the same time, we're delivering on global trials with a number of pharma studies as well as on the side of the vendors working through them to deploy on studies as well.Harry Glorikian: So in a perfect world, right, if you had access to all the relevant data, if every drug developer in the world was taking advantage of your services, how would it change the business of clinical trials? What would the outcomes look like? Would it be like you get more drugs approved every year, at a lower cost, fewer disaster failures, I mean. What changes for the industry and for patients?Rohit Nambisan: Yeah. I think the first piece is you would reduce—and this is a lofty question so I'm going to answer with a lofty response—the first thing to note is that, and we touched on this earlier, I think you'd see fewer bigger failures in the analytics phase. You'd be able to identify earlier on, both in terms of the lifecycle of a compound, right? So from phase one to phase three or even phase four, but especially within the study itself, you'd be able to identify that there would be an issue in the study earlier on and you could kill it early on. So that's one one aspect I think would be that's important to note. The other thing I think you would identify is less operational issues. So I think one in six trials across the globe failed just because of operational issues. And when I mean operational issues, I mean the protocol and the plans at the outset of a study say need to administer the study following these steps. And when those steps are not followed, there's compliance risk. And therefore, when there's enough compliance rates to throw out the data or you have to not submit the study.Rohit Nambisan: And so one in six is, it's not that small. And so if we're tracking, if we're more rigorously tracking both what is happening and what could happen, right, based on the indication, leading indicators of risk across time, cost and quality, we should basically never see -- that's a that's one of our major goals -- never see a trial fail just because of an operational reason. Not to mention, how can you go to the patients with unmet clinical needs in a particular indication in particular disease and say, “Oh, I'm sorry, while the drug probably was effective, we just couldn't get it out into the market this time. And it's going to take us another trial, potentially.” A lot of times folks don't actually resurrect the failed study, a failed therapy. So even if they resurrected it and said it was because of an operational issue, “Oh, you've got to wait another six years.” That's just not acceptable. So I think those are the two components that come top of mind. And I think early in our in our tenure, our mission was no trial should fail due to operational error.Harry Glorikian: What is the path to financial success for a company like Lokavant? Is it to just keep growing? To go public? To get acquired by a maybe by a big pharma. What's the path?Rohit Nambisan: It's a good question. I think folks that that know exactly what their exit strategy are probably, for lack of a better term, often deluded. But I will say that we've seen a lot of growth. Not only during, there's been a lot of interest in Lokavant during the pandemic, I mentioned we were in this externally subsidized R&D phase, we were actively trying not to do too much externally. We wanted to figure out how to set up the platform for success. Coming out of that phase, in the last six months, we've seen an incredible amount of traction externally. And so I think we are still in the path of doing it on a growth trajectory ourselves. What does that mean in terms of opportunities to collaborate both commercially and partner and strategically? Well, it means that we can only do as much as we can, even if we continue to grow. There's data out in the market and partners that have access to that data that we would love to collaborate with. If that means that we need to be more strategic in our approach to what Lokavant can do or how to structure Lokavant, we'll do that just because we need to actually achieve our mission, which is to have no trials fail due to operate operational error. Right. And so I think that requires more data. That requires more data science. We have a lean, very, very proficient data science team. So I think there will be opportunities for strategic collaboration, but it's all related to the mission of bringing this clinical trial intelligence platform to address operational and other risks in a study as effectively as possible.Harry Glorikian: You know, one of the things that crosses my mind is you could also use this from an investing perspective to analyze a trial that's going through its paces against historical information and determine, give it a weighting of probability of success versus failure from an investment perspective, that that seems attractive to me.Rohit Nambisan: Yeah. So that's an interesting point to bring up. There are folks now asking us in the market about what we've been informed firmly in trial execution stage. Folks are asking us to move into feasibility and effectively feasibility. Is that the planning of the study? Tell me with this particular configuration of sites, countries and for this indication, knowing the standard of care in different countries, knowing the approach to clinical care, not just clinical research, how successful would this study be? Right. And obviously, the success of a study, when you think about biotech, the success of a study is the success of the company. When you think when you go up the market, depending on the study, it can still have incredible impacts, the success of the company. So there is definitely an afferent towards the investing world and financial. I think at first we probably take a progressive step towards that by moving into trial planning analytics in this manner and then validating our approach against progress in space and seeing how we can continue to grow in that sector.Harry Glorikian: Well, Rohit, it was great having you on the show. I hope everybody enjoyed our discussion. You know, a lot of problems to solve in this industry. So there's there's no lack of opportunity from, you know, businesses that need to get started and the data that needs to be optimized to help move the process forward. But, you know, luckily, everybody I talk to on the show, that's the direction we're all moving. So hopefully we'll get there faster, because I'm not getting any younger. So, so good drugs are going to be needed at some point. So good to have you here. And I can't wish you and the team at Lokavant, you know, more success.Rohit Nambisan: Thanks, Harry, for having me on the show. It was wonderful to be here.Harry Glorikian: That's it for this week's episode. You can find a full transcript of this episode as well as the full archive of episodes of The Harry Glorikian Show and MoneyBall Medicine at our website. Just go to glorikian.com and click on the tab Podcasts.I'd like to thank our listeners for boosting The Harry Glorikian Show into the top three percent of global podcasts.If you want to be sure to get every new episode of the show automatically, be sure to open Apple Podcasts or your favorite podcast player and hit follow or subscribe. Don't forget to leave us a rating and review on Apple Podcasts. And we always love to hear from listeners on Twitter, where you can find me at hglorikian.Thanks for listening, stay healthy, and be sure to tune in two weeks from now for our next interview.

The Winning Edge Shawn Harper In life, we often face difficulties and adversities. Often, these things make us better. We learn from our mistakes. For some, they view life as being “out to get them.” The perspective you take concerning adversity will determine if you are a winner or a loser in the game of life. Our guest today knows what it is like to face adversity. He grew up with adversity. He struggled through adversity. But today, Shawn Harper is widely known for his unconventional ways, as his life journey dictates, step by step, how he overcame so much persecution and obstacles, that society said he would never amount to anything. But, against all odds, he proved them all wrong. He from the playing the bench for an entire year in junior college, to playing seven years in the National Football League for the LA Rams, the Houston Oilers and the Indianapolis Colts. Shawn is the author of https://www.shawnharper.org/products/ (“The Winning Edge.”) Shawn is also an investor, CEO and founder of American Services and Protection in Columbus, Ohio, and Bridge Builders International. He serves on the board of King's Ransom Foundation. Shawn is actively involved in his church and is a loving husband, father and family man. Help me welcome to the program, NFL great, Shawn Harper!  Shawn, it is an honor and privilege to have you on the program today! The first question I always start with is this. Can you tell us in your own words, who is “Aaron Shawn Harper? When did you drop the “Aaron” and start going simply by “Shawn?” You teach people about winning. What is the secret to winning that most people never grasp without someone, such as yourself, showing them this secret? My background in the Army, I did 12 years in the Cavalry and was also a drill sergeant, drill instructor. I know that you must train in the same environment and same intensity as you are going to fight. That is what makes us successful. You obviously did these things in football.  When was “that moment” when you realized you could enjoy enduring the pain for the rewards of success in football? The gifts of God are supposed to flow THROUGH us and not just TO US.  How do you help people to understand this concept in your coaching? You said, “Winners do what others won't do and winners do what others are not willing to do.” How has this type of attitude helped you in setting up your coaching business and how has this helped you to motivate your students to achieve success? In your NFL career, when did you come to decision to prepare a business for AFTER the NFL? When you decided to pursue the next level, did you hire a coach that could guide you towards your goals? Be it to the NFL and especially your business life after the NFL? How do you utilize, what you call, “leverage?”  Explain what that term means and how you help others to “leverage” their way to success… You also discuss the habits elite level athletes use to win in business and life. Can you share a bit about those habits? Tell us about your book, https://www.shawnharper.org/products/ (“The Winning Edge.)” How can someone get a copy of your book, “The Winning Edge?” Shawn, I do appreciate your time to visit with us today. If someone wanted to get in touch with you, to ask a question, invite you to come out and speak at their church or event, or possibly to do an interview such as this, how can they do that? What's the best way to get in touch with you? I'll put links to all of this down below in the show notes. Folks, in the brief interview with former NFL great, Shawn Harper, now a successful business owner, speaker and coach, you've heard some things that I believe will help you to achieve the success you were destined and created for. I urge you to go down into the show notes and reach out to Shawn. Be sure to grab his book as he is offering to YOU, right now, for free on his website! Praise God!  Just go down into the show notes and click...

Today's episode is the first of a three-part Pragmatic Folks series and we are joined by Dave Thomas and Andy Hunt to talk about the 20th anniversary edition of The Pragmatic Programmer. This new edition was not only an opportunity for them to revise the material but also to revisit their thinking and see how ideas have changed over the course of twenty years.

Folks…folks…ya gotta…ya just gotta. Go now. We don't even care if you skip this episode in the process! Just go see Ambulance if it's still in a theater near you! Yes. I know. We're saying you should give money to Michael Bay. Just this once, everyone…..unless he makes another Ambulance…then we'll pay for your ticket….no guarantees. Join the whole gang as they dip, dive, bob and weave through every little piece of mastery that is the newest addition to the Bay-verse. Check it and see. The engines got a fever of probably around 603. Sorry for the ad up top, but we didn't want to break the flow we all developed in another one of our adrenaline fueled in-person recordings. You're welcome! Thank you all for listening! Please remember to rate, review and subscribe wherever you're hearing us. . Many thanks to Matthew Roland Pharris for our artwork. You can find him/follow him and his amazing work on Instagram @pestopasta44 . You can find us/follow us on Twitter @AuteursVulgar, and on Instagram @vulgarauteurspodcast. You are also welcome to email us at vulgarauteurs@gmail.com about anything, and we mean ANYTHING. We have a spam folder, so don't get too excited. . We love you all! Go hug yourself --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

On today's program, Dr. Esly Carvalho continues to teach us about the various means by which God can heal the negative effects of sexual abuse and other traumas. 

FOLKS! Maniac and Slick is in for DA as we recap the past week as our community continues to look towards our teams and our leaders for unity. We are joined by Megabyte Ronnie to talk his upcoming 6 weeks and Jonny Lazarus to check in on his Victory Monday.

Imagine you lead a nonprofit that operates on a shoestring budget. Staff are paid minimum wage, lunch is bread and hummus, and you're all bunched up on a few tables in a basement office. But over a few years, your cause attracts some major new donors. Your funding jumps a thousandfold, from $100,000 a year to $100,000,000 a year. You're the same group of people committed to making sacrifices for the cause - but these days, rather than cutting costs, the right thing to do seems to be to spend serious money and get things done ASAP. You suddenly have the opportunity to make more progress than ever before, but as well as excitement about this, you have worries about the impacts that large amounts of funding can have. This is roughly the situation faced by today's guest Will MacAskill - University of Oxford philosopher, author of the forthcoming book What We Owe The Future, and founding figure in the effective altruism movement. Links to learn more, summary and full transcript. Years ago, Will pledged to give away more than 50% of his income over his life, and was already donating 10% back when he was a student with next to no income. Since then, the coalition he founded has been super successful at attracting the interest of donors who collectively want to give away billions in the way Will and his colleagues were proposing. While surely a huge success, it brings with it risks that he's never had to consider before: * Will and his colleagues might try to spend a lot of money trying to get more things done more quickly - but actually just waste it. * Being seen as profligate could strike onlookers as selfish and disreputable. * Folks might start pretending to agree with their agenda just to get grants. * People working on nearby issues that are less flush with funding may end up resentful. * People might lose their focus on helping others as they get seduced by the prospect of earning a nice living. * Mediocre projects might find it too easy to get funding, even when the people involved would be better off radically changing their strategy, or shutting down and launching something else entirely. But all these 'risks of commission' have to be weighed against 'risk of omission': the failure to achieve all you could have if you'd been truly ambitious. People looking askance at you for paying high salaries to attract the staff you want is unpleasant. But failing to prevent the next pandemic because you didn't have the necessary medical experts on your grantmaking team is worse than unpleasant - it's a true disaster. Yet few will complain, because they'll never know what might have been if you'd only set frugality aside. Will aims to strike a sensible balance between these competing errors, which he has taken to calling judicious ambition. In today's episode, Rob and Will discuss the above as well as: * Will humanity likely converge on good values as we get more educated and invest more in moral philosophy - or are the things we care about actually quite arbitrary and contingent? * Why are so many nonfiction books full of factual errors? * How does Will avoid anxiety and depression with more responsibility on his shoulders than ever? * What does Will disagree with his colleagues on? * Should we focus on existential risks more or less the same

We are, as a general rule, living longer. The average life expectancy of Americans in 1960 was just over 69 years. In 2022, it's 79 years. A team of physicians and researchers at Johns Hopkins University have formed a group to study ways that we can stay healthy as we get older, exploring medical and technological fixes for what might ail us. Dr. Jeremy Walston is the director of the Johns Hopkins Human Aging Project and Raymond and Anna Lubin Professor of Geriatric Medicine and Gerontology at Johns Hopkins. Dr. Walston joins us on Zoom from Baltimore. Dr. Peter Abadir is a scholar at the Human Aging Project. He is an associate professor of Geriatric Medicine and Gerontology at the Johns Hopkins University School of Medicine, and he holds a joint appointment in the School of Engineering. Dr. Abadir joins us on Zoom as well. Folks over 65 who would like to volunteer for the Human Aging Project can contact the team by email at hap@jhu.edu, or by calling the Healthy Aging Studies Unit at 410-550-2113. For more information on pathways to staying healthy in your later years, follow the link to Hopkins' Aging Well Website. See omnystudio.com/listener for privacy information.

In this weeks episode, Clay and Tanner create a tier list for many of the most popular Viral Dance trends. They look at dances from the past 2 decades such as the Dougie, the Whip, NaeNae, Shoot and many more, discussing ultimately where each dance falls in the rankings.Soul Serum:https://discord.gg/Ny3rjqshttp://www.twitter.com/souIserumhttp://www.instagram.com/soulserumhttp://www.soulserum.shop

Lots of famous folks are closing shop and "retiring" from coaching and online business. Some people are asking: "Is the coaching bubble bursting?" I don't think so. Grifts and pyramid schemes and “coaches” by different names are part of the historical fabric of capitalism. Remember Episode 13 and Napoleon Hill? He was a business coach before we had that term! There will always be more people desperate to “get rich quick.” I think people leaving coaching and online business aren't evidence that the bubble is bursting but that their bubble is bursting. They are burned out and, more than anything, realizing that the only ways to continue “scaling” at massive rates are unsustainable and unethical… Coaches aren't going away. The world is hurting right now and there will always be people who need support...or want a magic pill. What we're seeing is turnover. For all the burned out folks leaving, there are endless ready to come in and take their place. Why do you think so many business coaches target brand new entrepreneurs or hopefuls eager to give their “two weeks notice” (the title of Amy Porterfield's upcoming book targeting folks with day jobs who want into the online business economy). Because this audience is green and hasn't been around long enough to notice the patterns. This is how folks like Tony Robbins & Dean Graziosi continue to scale. With partners like Jenna Kutcher who give them access to a brand new audience of folks who've never heard their sales pitch. Folks who don't realize much of their business advice is available free on Google. Filling a funnel with newbie entrepreneurs is part of the strategy for gaining “transformational” testimonials. The info they sell in their programs is elementary but to a new entrepreneur who has never heard this stuff before, it feels MIND BLOWING. So do I think the coaching “bubble” is bursting forever? No. I think we can expect more regulation, yes. But just like “diet pills,” sellers will simply adapt and change their methods. The worst coaching weaponizes the desperation people feel within capitalism. As long as people are hurting, others will sell to that pain. Who doesn't want any easy way out? Tale as old as time. The problem is the system that puts profit > people. Not a few unethical coaches. I see many folks peddling the message that wealth building is a feminist endpoint, specifically. But this denies the reality of this economic system. Extreme wealth (or wealth, in general) is literally impossible for all people within this system. Selling wealth as the solution without a critical analysis of the reality of capitalism is just more of the same. We can't buy (or sell) our way to a better world! This episode of Marketing Muckraking is all about the question: "If the coaching bubble ISN'T bursting for good, then who are the GOOD coaches, RKA?" Can you give me a LIST? Make it easy for me. I'm kinda exhausted by all the muckraking. I'd like some feel good answers. Well I've got answers, alright. I pulled this episode from the FREE SCHOOL archives. Last year, I did a live in June 2021 about this very question — “Who are the good coaches, RKA? Who can we trust?” Listen up — it's a wild ride! You meet my character Brad the Braggy Bro and learn his back story. You get a peek at what I teach in my keynote speeches about reverse niching. And you get my answers about who are the coaches you can TRUST, dammit! Buckle up. Let's go on an adventure... And you can download the reverse niching exercise I discuss in this episode here: http://reverseniching.com/

CW: Images of torture, being chased in a dream, aggressive, repeated sounds, sudden loud noises, discussion of death, depictions of poverty Twitter: https://twitter.com/roomwherepod Discord: https://discord.gg/ZjwPuRv Website: https://roomwherepod.com/ Patreon: https://roomwherepod.cash While it may not be from here, dear viewer, nothing embodies the history of Appalachia more. I came from somewhere else and began to make space for itself with no regard to what was already here. Folks were even encouraged to plant it during the 30s.Whatever helpful properties it does have, however, don't outweigh the bad. Pushing the life of this place out. Taking land that wasn't it's to begin with. Strangling the life out of something else just to get a little bit more. The history of Appalachia summarized in one vine.

Folks, on this week's episode we hear about a guy calling 911 too much, a kid who accidentally ordered 31 cheeseburgers, why scallops really love disco lights, how a squirrel stole a golf ball during a big tournament, and how one lady taking a vacation caused a whole town to shut down We're doing another live show this July 8th at the Gutter in Greenpoint, Brooklyn! Tickets available now! (Are you a patron? Check the Patreon for discounted tickets! Or join right now and get the discount!) https://www.eventbrite.com/e/what-a-time-to-be-alive-live-at-the-gutter-tickets-337420623167 We are on Patreon! Become a patron for weekly bonus eps and more stuff!: www.patreon.com/whatatimepod Check out our YouTube channel: https://www.youtube.com/c/whatatimetobealive Get one of our t-shirts, or other merch, using this link! https://whatatimepod.bigcartel.com/ whatatimepod.com J oin our Discord chat here: discord.gg/jx7rB7J @pattymo // @kathbarbadoro // @eliyudin // @whatatimepod © 2022 What A Time LLC

Folks, we are shocked and appalled that none of you have ever yelled at us for never having done a Mercer Mayer book on this podcast. We're onto episode #227 and in all this time, Mr. Mayer has never once graced our eyeballs. Today, we correct this longstanding ill. Take a listen to this if you would like to hear Betsy's off-the-cuff recounting of all the Mercer Mayer books that we haven't done. She also go into tangents on the awfulness of feet in early 80s footie pajamas while Kate engages in The Great Tissue Box Theory. Show Notes: Not sure how much credence to give to the working theory that this book is referenced in Alice Cooper's Welcome to My Nightmare. It's a great idea, but the monsters in this don't really resemble the one in the book. Just our two cents: https://www.youtube.com/watch?v=Kum-q6RfPAw Whereas this video of the book is most certainly narrated by Michael J. Fox. So that's all good: https://www.youtube.com/watch?v=cpGPYXSPSxQ For the full Show Notes please visit: https://afuse8production.slj.com/2022/05/23/fuse-8-n-kate-theres-a-nightmare-in-my-closet-by-mercer-mayer/

The Athletic's Ben Standig is back from vacation and ready to take on Commanders OTA this week with guests Brad Spielberger (PFF) and Chris Russell (Team 980). Ben opens the episode with some vacation details that intersected with his day job and reacted to a report about NFL owners growing tired of Dan Snyder. Then Brad joins (10:20) a ranting Ben for a lively discussion on what everyone has wrong about Carson Wentz's contract and Washington's salary cap scenario in connection with ownership and lack of spending. The Wentz talk continues with Chris (43:10), but the fellas also get into pure football talk. What can we expect from a Scott Turner offense with a QB capable of making all the throws? Did it make any sense for Washington even to consider signing James Bradberry? Plenty more Commanders/OTA topics as well.

Featuring: Ammosart, Ashgar, Belghast, Tamrielo, and Thalen Tonight we are down a Grace and a Kodra but carry on with the long list of topics left over from last week.  We start the show with a discussion of Trek to Yomi and how it is the video game form of a samurai movie.  Bel revisits New World and talks about all of the improvements, and how it is very unlikely to change anything population-wise.  Folks played Necromunda in person using the 2018 rules set and share their experiences.  Bel talks a bit about his rabbit hole from last week of looking at just how far off Kickstarter estimated delivery dates are for Video Games.  Finally, we talk some more about Star Citizen and the 3.17 patch, along with some long-time daydreaming about a world where Tam gets to ferry us around the galaxy going on delves through abandoned space hulks. Topics Discussed Trek to Yomi New World Improvements Necromunda Kickstarter Nonsense Estimates Star Citizen 3.17 Always Pay Your Sheep in PVP

The thing with real estate is, how do you market your business? I don't believe we're in a sales business. I believe we're in a service business. Our guest today is gonna lay up what she's doing. One of the things that is her claim to fame is that she does things differently. She's not scared to put it out there. She's authentic. She's real. She's raw. She just tells it how it is, and that's what we need more of in this business. We don't want any more fake fake fake fake fake it till you make it type of brand new marketing and all that. We want real and authentic shit. So we're gonna let her school us today about secret to her success and how she's gotten over $700 million in sales.Maria is a real estate agent, executive and expert, innovative entrepreneur, investor, speaker, visionary, trainer, thought leader and philanthropist with over 25 years of experience.Three Things You'll Learn in This EpisodeHow to make your content stand outWhy being authentic is better for your businessWhat content you can offer your audienceResourcesLearn more about Marie QuattroneReal Estate Marketing DudeThe Listing Advocate (Earn more listings!)REMD on YouTubeREMD on InstagramTranscript:So how do you attract new business? You constantly don't have to chase. Hi, I'm Mike Cuevas a real estate marketing dude. And this podcast is all about building a strong personal brand people have come to know, like trust most importantly, refer. But remember it is not their job to remember what you do for a living. It's your job to remind them let's get startedWhat's up ladies and gentlemen, welcome to another episode of the real estate marketing dude, podcast. Folks what we're going to be doing today people have been asking me Hey, dude, why don't you have more women on once you have more women on? Why do you always have all these dudes? Why are you having a sausage party podcast? Well, we're gonna bring on a killer women today that is going to share with you her secrets of success. Not only is she own her own office right now, but she's been in real estate for 28 years, I thought I was the only person who could say I've been in this business for 20 years. Well, she's gotno 18 years of real estate 11 years in marketing. So marketing sales,love it. That will this is what we're gonna chat about is like, you know, the thing with real estate is like, how do you market your business? And I don't believe we're in a sales business. I believe we're in a service business. And I've always been known to like, do things differently, stand out, Chase attention, don't chase leads, stuff like that, man, she's gonna lay up what she's doing. One of the things that sort of has her claim to fame is that she does things differently. She's not scared to put it out there. She's authentic. She's real. She's raw. She just tells it how it is. And that's what we need more of in this business. We don't want any more fake fake fake fake fake it till you make it type of brand new marketing and all that. We want real and authentic shit. So we're gonna let her school us today about secret to her success and how she's gotten over $700 million in sales in her career. It's a lot of business guys. So without further ado, let's go ahead and introduce our guests. Mrs. Madea Quattrone did I say that correct?You did. So Italy, though? We would say quick, Joan,I was gonna ask you're either Italian or you're Hispanic. And I was gonna guess one or the other. But cut Oh, no. Okay, cut there. Oh, no. Tell us everybody. Tell everyone who you are, where you're askingme my slide here. Thanks for having me on the show today. I appreciate you and your time. So yeah, I mean, real estate is all about marketing, I don't care actually what business you're in people who need to know who you are. They need to know who you are, and what you do, and how you can help them. So first things are, you know, you start with the basic things, you can start with marketing, marketing yourself, just by picking up the phone and talking to people. Mark, this is how I started. I started by picking up the phone and talking to people, and going to networking events and marketing myself at networking events, doing the simple things consistently over and over and over again, following up with that person that you met the night before, at the at the networking event. Right, doing those putting those little touches, I always remember something special about that person. Whether is, hey, their kids go into Howard or, you know, they, whatever they do for for fun, they they got a lot or whatever it is, there's always something in the conversation. I remember and I always revert back to that, as I'm getting to know somebody. So the basic principles of marketing are get people to know who you are. And you can start simply by picking up the phone and by meeting people face to face. How can you do that now even more authentically, right now video? Getting on video giving. So what can we offer? I will just do real estate things. I talked about being inspirational.Everyone thinks we have to talk about real estate though. What do you mean? Do you mean I could do a video and not talk about interest rates houses are just sold or how many fucking houses I sold last month or how much money I made. I could actually do that and generate business and real estate you got to be kidding me.Right, so our core value one of our core values here at M QA is to be the solution. That's my personal core value and top of integrity and a lot of other things but for this talk today be the solution. And so I started this podcast called The the solution because here's why. It was March 20 2020 The governor shutdown boom, boom, boom real estate here. Couldn't go out of the house to go sell real estate or go to networking. So I'm like, Oh my gosh, what are we gonna do? Guess what everybody's eyes were social media. Yep. everybody's eyes were in social media. Social media went down from like, 20% like that during the day that 80% Everybody's on social. Yeah, guess what? All my colleagues around here. Nobody was on social say nothing. Yes. Well, I said it To be the leader, and I'm going to step up, and I'm going to be the solution. Because our clients have hired us over the years, especially, we sell expired listings. Why? Because we're the solution for them, because they haven't been successful in the past for a variety of reasons. And hey, y'all, it's not always the agent. And I don't actually blame anybody. But I come up with the solution on how we're going to do it. So it's March 20. I'm like, oh, no, F. At WTF. Freaking out. Yep. Soit's about that time really quick. Yeah. And I said it here on the show, we said the same thing we go listen, this is when you double down on brand, because this is when everyone's gonna be glued to social. And I'll be like, we lost a lot of our clients at that time, because we're creating videos, but the fear went through the industry so quick, that the truth is, is that all you guys who are still listening to my show that quit, you just made a major mistake, because you just lost a shitload of attention. Everyone who doubled down on video during that time, literally had a 4x from the year prior. Because it's all attention based guys. And you have to remain present. It's not about what you create. It's about that you're consistent in presence. And I agree with you, I agree that I think this whole business is just about having conversations, constantly and constantly reminding people where you're at and who you are. And when the networking goes away. How do you have those conversations, you go to social and you do it on video, because those videos are still playing while you're sleeping. And they're always working for you. But whether it's video or whether it's not what we're getting at, folks, is that you have to be present. Alright, look, if you Maria, are you married? I am if you stop talking to your significant other for the next month, what's going to happen to your relationship?Don't very much it's good.I have nothing at all. You know,you've been zero is gonna happen. So guys, what do you think go for like a debt? Not even like a half a day without talking? Maybe like a day? But no, I mean, come on. You have to talk to people. UntilWhy do agents agents stop talking to their databases? Like when I moved out to California five years ago, I was shocked at like the way that I saw some agents actually treat their clients and how they interact with them. And folks, like you don't spike the football on a transaction a day of the closing table, you spiked the football on the transaction, the day you get your third referral from that person you had at the closing table five years prior. And we're not playing the short game. We're playing the long game here. You have to remain present since like Maria, let me ask a couple questions. You have a bro, how many agents are in your brokerage? There's about 15. So 15. Besides you I know you're probably the top of your killer, who's the other top agent besides you? What's your volume like?So we run our office like a team. So we work together. So Dara is my listing partner. So she does a lot of the listings now. Probably, I'd say the lion's share. And then we're grooming some other agents to step up into the listing because we believe in listing listing listing listing, I get buyers organically. So I'm trying to focus on you know, we opened up another business, I'm also building that so and we're recruiting people into our company so that we can help them grow. So I've actually stepped in a little bit more of a sales manager role training. A little bit on the recruiting side, I have like a help on that actually. And we also have a scholarship program. So we're bringing new people that have never been in the real estate industry, we specifically look to bring in women and minorities. And we have a program for them. It's called the M QA scholarship program. And it is from the moment that they we agreed to we're going to be partnering up together until they finished the boot camp, we offer this entire package. So schooling mentorship during schooling. And then we have a two week program called rise in Real Estate Academy that is here on site that they go through. And then after that, they are position to have the basic knowledge in order to conduct the buyer Strategy Session, show houses and basically write the offer but to get the offer training is going on going because that takes a while to figure out so we we gear them up, they actually are making calls on day two. In our program, we used to do it a little bit later, but we found that quicker is better. We want people to get used to talking to people that's why I lead with you have to talk to people I we could do all the marketing in the world and if we didn't talk to anybody, right it's a waste of money, waste of time. So like going back for a moment to you know, 2020 the podcast was born be the solution because As I couldn't go anywhere, so I didn't see any people. I was heavily involved in sales at the time. And I was figuring out what we're going to do for who knows how long in our case, it was 10 weeks. And every day for No, three days a week, I went live on Facebook. And I never did that before in my life. And I had been interviewed over the last two years about 150 people, which, you know, for somebody who's not there, like full time gig, kind of a lot of good amount of people to get good at listening. Yeah, so there's more things that happened because of podcasts. So then what do we do with the videos, right? So I'll make a video about, hey, this week might be the solution messages. And during the times the hardship that we went through many people with being sick family members, sick people dying, people are really on a ledge, right? So I came up with every week with an inspirational thing to talk about, of it. And I talked about, you know, family, and I talked about perseverance and, you know, just continuing to go on, you know, to keep going keep going in all different topics, but like geared around being inspirational, andit's all based around. So a lot to unpack here, guys. Let me just so here's, here's what she's walking you through is you one creating content to have conversations. Okay, so we're talking about content creation, and being consistent with that. And even though someone might not necessarily be talking back to you, when you're creating videos, you're still having conversations, because someone on the other end of those is listening, even though you're not responding back. However, it's very hard to do anything in longevity consistently without first determining what the hell you're doing, or what your strategy is. So she comes up with a concept called be the solution be the solution be the solution. And basically, every bit of contact content that she creates, has a theme associated with based upon being a solution. So the problem that a lot of people have when they're coming up with their content strategy, as the real estate coach will tell them go out shoot videos, and then they'll go out shoot videos, but they don't really have any purpose or meaning, or do anything to enhance the brand. It's just a way to start a checkbox, check the box, because your coach told you to do. So she's taken it up a step, because the truth is, if you're going to create content you better well, we might as well make it impactful. And Maria, I'm guessing we just met about 20 minutes ago. So we haven't talked before. But I'm guessing that she's an avid reader of inspirational stories, she probably reads a bunch of biographies. But a bunch of different people have gone from zero to hero, my guess is that Maria probably was a zero back in the day. And now she's a hero. And she has a work ethic from somewhere some way shape, or form. I'm not sure where that came from. But you can tell by her personality today, it means something. And folks, each of you have the same thing. It might not be the solution. But it is something that makes you unique, because God's only made one of you. And that's very damn cool. Right? Everybody has a personal brand. The problem is that nobody's ever no one embraces it, because you're so worried about what everyone else is gonna say about you. Maria here doesn't give a shit what everyone else says about you. Maria knows how to inspire change. And she's marching to the tune of her own drum. And because of that fearless ability to create content, Marie, I'm gonna go out on a limb. People were probably reaching out to you at this time in 2020. Being like, these are the private messages you guys get when you start creating content. I got them. I've been getting them all week, I'll share with you what I'm doing now. But Maria, thanks for you know, I really needed to hear that today. Thank you so much for just sending that message over. Hey, Maria. Hey, guess what, you know what I was even thinking about my kids learning center and how I can improve that. But just because you did that video, thank you so much for for doing that video, you know, I'm stressed out, I'm worried about losing my time. So tell me what happened when you start creating these videosI got so what happens not only just creating the videos, but then we send them to not only post them on Facebook, and do the lives on Facebook, which are separate. That's different. Also sending it out to our database of 14,000 people or so. So what happens is the people, some of them may not respond, but I know who opened it. And a lot of people did respond to it, especially during that time saying, This is awesome. Thank you so much. You know, I'm inspired by you, and I can't you know, thank you for stepping up all kinds of things like that direct messages, text, put post on the Facebook, you know, video, but a lot of it. A lot of it was you know, privately, and even people telling me when I'm around and about like I see yourself, you're everywhere, blah, blah, blah. So one thing though, that I want to mention is really important. So one of the things that we talk about here at M QA is that the money's in the database all the time. All of it, it's a goldmine. And when people, agents join up company, they it's plug and play their plug in right in right into our database to follow up boss and all the other systems you use. And they're calling people that already know us. Because guess what they've gotten. If they'd been in a database for three years, or close to three years, they probably receive 140 ish videos from me. So what happens? Mike is, I'll be at my office, and there's people coming for settlements, and the really cool Maria. Yeah, I watched, I've seen all your videos.Are you like who? Who are you?I'm always I'm always very gracious. And I say thank you so much for the opportunity for us to work with you and your family. And so they know already the brand. So when anybody ever calls, I say 9.8 out of 10, maybe 9.9 out of 10 times that people are nice on the phone. Because they're like, oh, yeah, that's Marine, we're not ready yet. Or maybe we'll sell this or we got investors, you know, oh, did they have this or that or whatever. So you're using this as a platform to sell your brand without selling it by giving the community information. So it could be a market update monthly, it could be solution oriented, like these are be the solution podcasts and talking about motivational or inspirational either or both, by the way, not just as free servation as well,you were saying you guys is without a brand, you're just a salesperson chasing the next Chuck. And there's nothing different between you and somebody else. But the only way you could create a brand is through consistent communication to the same audience over time, because of Maria, when Mia, those same people that are having settlements in your office equally walk right past, you not know who the hell you are, the difference is in brand. And that brand brand brand brand brand is the only thing we have to compete against every everybody else. People aren't like in your market. They're not like hiring a real estate agent. They're hiring Maria Maria's team because of what her brand, or what they believe her brand can do for them, which is probably stress free real estate transactions. But she doesn't get the opportunity to have that conversation without first being top of mind or creating content. And you hit it right on the head. What she's telling about is the database, it she's 100%, right 10 to 15% of the people who see your content will be moving this year, and 100% of them have a referral for you. It's just a matter whether they're going to share your name or not. And the more memorable, the more authority you have, the more bigger your brand is, the more likely you are to be introduced to those conversations. And that's called attraction, guys, which is what it is, but you can't get there without first creating content. And content takes a lot of different shapes or forms. We're talking about video right now. But content creation has been around since the dinosaurs ruled the earth. Back then remember, back in the days, it was just direct mail, I started off with direct mail, I used to farm my database, I still do find my database. And I just say Don't forget to exist, it's not about the content that I care so much about, it's more about keeping my face in front of them. And a value added way that hey, don't forget I'm in real estate, oh, by the way, is something you can add value with to deduct your daily day.Indeed, so when the other thing that's really important when you are working within the database, and let's just say that's how you're working your business, is that you can create in most database, at least in our follow up campaigns. And the follow up campaigns in our case are mostly 80% video. So you may be a seller who's going to sell and three months from now. And we want to inform you of different things that you should think about maybe when selling your home or the marketing that we do or you know, how to increase your home's value for a little bit of money. Or if you're a buyer, you know why buying now is critical, versus you know, what's going on and also what's going on in the marketplace and what to expect over the next five years in regards to the market normalizing but it's still gonna grow over the next five years 19 20% which is a healthy growth after, you know, this year, which are probably more like 79. Who knows. But if we're at three to four, that's normal. But if you're not, if you're a renter, you're out of the game. So videos about all these different things and putting people on these proper, what we call action plans. And so here's another touch and another touch and you're educating them. And you were there's no ask involved. No, it's rare that we do an ask and the only answer usually that there is, is would you like an updated market analysis for your home? Yeah.Or do you know anyone else that needs my help?Yes, on the phone, we usually do that usually get on the phone. We ask that question,why through your guys's touchpoints and the different channels you guys are using overall. So let's just say I'm a new agent. I'm in the Philadelphia area. I'm like one to two years in business, but I'm only doing six to 12 sides a year and I can't break it up. I'm listening to one of the gurus, they're telling me that I need to pick up the phone and call a bunch of people I've never met before or go knock on some stranger's doors, or go buy very expensive leads. What do I do in your system?In our system, if you joined our company? Yeah,walk me through it. I'm gonna see all the touch points.While the campaign is happening, there's, we have about 20 different campaigns that run because they still in what type of opportunity, they are past client, active client. Buyer, short term buyer, long term investor, multifamily industrial buyer, commercial development buyer, commercial development seller. So that's we have a lot, a lot more than the normal people do. Because we do do commercial real estate as well.What about just past client, like stay in touch type stuff, let's pretend I'm not buying or selling? And because we got to be top of mind first, right? Otherwise, we don't get the tab that a conversations about being a commercial buyer and investor any that still have to remain present? How are they staying in front of their databases that are generating the calls to become and talk about commercial property or selling the listing or something like that?Well, we have we do inside sales. So we call into the database every day. And like I said, they get these weekly, those videos or weekly, they go to everybody. So that is an overall company message that goes out, then you have the action, then you have the action plan, segment it per the source of business. So those action plans are running. So every time we have a new person come in to our world in art, we put them in a database, and they go into a bucket. And the bucket works the opportunity until they're ready. And in the meantime, the agents will touch base when they're told to touch base for the action plans and tasks and follow up boss.And it's probably like a text, a phone call talks an email, what's the combo of touches Video,Video, an email, and then our text when we do texts? There's not there's no automatic, it's texting for specific reason. Like we'll have a day we'll do you know, we might do 50 tax to sellers saying Would you like an updated Mark analysis? But that's not we're not blasting anybody with anything like that. It's good one. It's yeah, you have to be careful with that kind of stuff.Yep. I like it. I like it a lot. So you're creating with your team, you're sort of creating the core content from the top and then syndicating it down to and then your agents are curating it to their networks and their databases, but you're centralizing the branding and the communication as a team, which is really smart. And that probably is what keeps them consistent.Yeah, so everybody uses everybody uses the same thing. So we have one buyer presentation, one listing presentation. Everything is the same. Everybody uses the same. That's why our agency runs as one big team office. I don't believe in having 50 different agents doing 50 different things. That's problematic.And I have a brand doing that. It'd be like McDonald's having 20 different types of cheeseburgers. People go there for some cheeseburger.You'll see some brokerage that has brokerages I won't name any names that have every person can have their own type ofsign 99.9% ofthem. Yeah, and but even though to the brands is x, x Yeah, initials. Yep. And then there's a pink one, a yellow one a black and white one was at least with REMAX right, we just have we do say brand specific and that's important. People know that REMAX brand even though we our own our own brand here in Philadelphia Maria Quattrone associates you know there's nothing not too bad to be on the back of a giant Yeah,I agree. What um, so let's go let's go what's coming down the pipe? I think you're 100% right on what's gonna happen with client generation going forward? There's a lot of changes happening Do you believe Yeah, let me second the young packs I see already dirty. What's gonna happen like how are agents gonna find their clients because before is more like there's so many different ways to find clients but remember guys What worked 10 years ago doesn't work anymore, or as good as it used to so probably Maria around same time we both got in I started oh two. I was told to cold call a lot and that's how I got my first few sales but cold calling today isn't quite what it was back then. At the same time, we didn't have text back then today you do. So what are gonna be the sources of business with all of this stuff coming down the pipe, you have ibuyers bleeding, the drowning the airwaves about how realtors are a big waste of money. You have commission compression that is for real, it's happening. You have a lot of alternatives and selling, depending on where you're at in the market, maybe not so much in Philly Metro, but the eye buyers, the open doors, offer pads and all of those these world, they're gonna be in every market guys, like trust me, we see all the shit coming down the pipe, and we know exactly what's coming. There's a reason why we're adapting now to be ready for those messages. So what what is an agent gonna do going forward? Where do they hang their hat?Build a personality brand? Yes, I agree. Feel content, build a personality brand. Make sure everybody knows what you do. Spend your money and time. Do you know what we call? Dedicated, dedicated, intentional, intentional content. So you're spending four hours, six hours a week, blocked out three could be three hours, where you're building intentional content, you're building an arsenal content, hire a VA, to edit your podcast, start a podcast, I could teach people how to do that. Starting a podcast. Right? What other things can you do to build your brand? Everybody who's an entrepreneur should have a podcast? Would you agree, Mike?Yeah, I think everyone needs to have content like it, whether if it's gonna be a podcast, it's gonna be a video series. It could be a blog, it could be a meme series, but you have to have content. If you don't have content. No one knows who the hell you are.It's so easy to do with so you don't even have to have original ideas anymore.No, you just you follow Maria's feed and just copy what she's doing and put your own spin on it guys, like,go into one of these large Facebook groups or with all the complainers and see what they're complaining about and do a video.That's actually probably that's how you get the solution content? No, because that's a good idea.You guys, not because it's like more thought. It's a little more thoughtful. And it's not real estate related. So it's for all humans, not just people in the industry. But we do produce content for agent attraction now as well as consumer attraction. Yep. So we have videos for both. And then we have videos just for everybody.Yep. You have to, and like, let's just get you like inspiration, we'll get out of your brain just we give some people some other things to think about. If you're like a health nut, like give me workout tips, like, you know, like, if you could be a lender and you can be super into fitness, well, you probably have a healthy way to finance a house. But you could still give like, give me your protein shake recipes in the morning, nobody cares. But you're always going to attract the same people. And that's where you have to build an audience. Because regardless of what you're talking about 10 to 15% of the people who do listen to what you're saying are moving, and all of them have referral for you. So it's just a numbers game. The guru's tell us to go out there though, and just chase like prospecting calls. And you guys, this is just a different way of looking at our business comes to you. So let's go with something everyone's familiar with. If I hire guru coach, they're gonna come up to me and say, You're one more know away from your next Yes, just keep hammering that phone, Mike, just keep hammering. And that's true. Like, if I throw enough shit at the wall, something's going to eventually stick. When you're talking about content creation, though there still is a number or mathematical formula there. And it's the numbers I've been saying earlier. If you're out and creating content, if you're creating a video, that means 10 to 15% of the people who see your video on your Facebook, feed your IG feed your LinkedIn feed your email list, your YouTube channel, whatever it is 10 to 15% of people who see that content they're moving this year. That's a mathematical fact, it's not nothing that we can change. Most don't know it yet. Some will die, some will be relocated some of this and we'll do that. We don't know when a move happens, life situation happens. And they raised their hand and 88% of the people who meet with the first agent, that's who they end up hiring. That's why this stuff matters. But that's not why I'm marketing it. I'm marketing my database because 100% of them have referral for me. So let me give you another example. I just onboarding an agent onto our team. Traditional sales agents, what I typically see always selling, selling, selling spending $2,000 A month sending postcards to a bunch of strangers. I'm like, bro, I would rather just gift 20 People $100 each have a gift and you'll end up with three or four deals. Why are we trying to talk to strangers? Why don't we just nurture the people you already have? And they'll give you direct business. But he goes, Mike, I don't want us. I'm not going to put these people on my email list or my direct mail list because they don't have any money. I go, Dude, you're missing the entire point. We're not staying in front of them for their direct business. We're staying in front of them for their referral business because everybody has a referral for us. You'll just happen to get their direct business as a byproduct of that and that is straight mindset. If I'm constantly messaging people with the intent of selling them something it's very hard to stay consistent with my messaging. But if I'm constantly messaging people adding value like Maria is, with the concept of I'll be the solution and giving friendly advice. It doesn't matter because of the audience that she's built. What she just told you guys was 14,000 people in her database. 1400 of them are moving each and every year 1400 1800 of them, and then probably about 20, well, all 14 of them have referral. So it's not about reaching and hitting masses and masses of people as much as it's about resonating. And really owning that core 200 250 people that you already know, like, trust and love you they invite to your wedding or funeral, or that you did say hello to the grocery store. Strangersyou want to do is to get to be the news to get in front of the news. So, you know, when the LA Times I think it was today or yesterday, there was some BS about the world's ending real estate's gonna crash blah, blah, blah,big bus script you could do right now is look is the Philadelphia real estate market going to crash?Right? So you want to get in front of it. You want to last week when the Feds announced a rate hike? Immediately, I did a video about it. The video was the Fed just announced the rate hike the first time and 22 years it's been half a point. What does this mean? Hey, it's we're in a courtroom with M QA blah, blah, blah. What does this mean to you? Well, guess what? The last time this happened was the.com. And it was 22 years ago. And you know what happened? Interest rates 3%. And you know what happened after that happened? Interest rates came down. Yep. So the part of the world went into recession, but the rest of it, real estate actually raised in value. Right. So I did this video, but I did it immediately. You have to be an action taker. You have to be an action taker, you cannot wait, you have to get on in front of it. So, uh, you know, you want to get your market update out, you could do a weekly minute update. About you could do it about whatever's going on. Open up the Wall Street Journal. Look down the page, look in the real estate section. For ideas. Put it in Google, you can go to answer the public.com. See what topics that they like that they want to know more information about. Go there. Do the video. If you use you can use big view. You put it right in the teleprompter. Write it up, put it in teleprompter, put it on your you can put it on your computer, you can put it on your iPhone or whatever phone he has. Put it up there, put your ring light on. That's it. You got a video done. Take it upload it you can either put it to Jarvis AI now or if you rev.com translate the thing make sure you got captions on. Because most people we know that 70% of people watch the video with the video with the sound off. We also know that one minute of video equals 1.8 million words. The impact of it is 1.8 million words. It has on somebody the 400 that 400% greater impact than 1.8 million words.I like it. Yes, folks. Dude, you guys got a great content. I mean, I don't know it's not a nice way to put it. You're in the best industry to create content in. Everyone's always interested in some way shape or form of it. It doesn't always have to be real estate either guys, like if you don't wanna talk about risk, they don't most of our clients don't ever talk about real estate. But you can if you want and it just matters on what you're passionate about. What matters is that you're passionate. If you're not passionate about whatever you're talking about, it doesn't work when you're on video and you're smiling it always works I don't care what damn business you're in. We're gonna Why don't you go ahead and tell everybody if they want to learn more where they can find you and all of that we'll get this thing laid up.Absolutely, they can find me at the the solution podcast or so by MQ on Instagram. And my name Maria Quattron on Facebook. And you can reach me if you want to give us a call 215-607-3535 for your Philadelphia Metro market connectionif you're a badass woman in the Philadelphia area because it sounds like this is a woman only team correctno we do have men to take on man wellif you're a man that can keep up with these women Okay? Which I don't think you can they're probably run fucking circles around you call her up and maybe she's looking for some more team members in that area and obviously she has 1400people so if you want to have business we have it for you. If you're hungry, you can easily turn your first year business year you can make six figures no doubt and I'll back that up with money.Love it, love it. Love it and thank you folks for listening another episode folks if you need help getting on video we script at it and distribute your content. Put you on the map tell you what to say teach you how to do it and then multipurpose it to your channel and everything else that you can imagine for it. This is not rocket Science I believe it's a popularity contest and if you want to create get more popular, start creating more content videos just the most impactful way that you can do that and we can certainly create a done for you for a solution for you on that just visit our website at real estate marketing do.com real estate marketing do.com and connect with those aren't channels. Thank you for leaving your reviews, keep them coming and reach out to us. If you have any interest about how any of this stuff works. Reach out to Maria, please feel free to reach out to us schedule a demo, visit my website. I'll follow you around the internet until you do and we'll go from there. Appreciate you guys listening. We will see you on next week's episode peace Thank you for watching another episode of the real estate marketing dude podcast. If you need help with video or finding out what your brand is, visit our website at WWW dot real estate marketing do.com We make branding and video content creation simple and do everything for you. So if you have any additional questions, visit the site, download the training, and then schedule time to speak with a dude and get you rolling into your local marketplace. Thanks for watching another episode of the podcast. We'll see you next time.

Folks, Doug is still under the weather. Despite his ailments he pulled himself out of bed and provided you, our very important listeners, a damn fine podcast. Both he and Bill go over Johnny Ace, AEW action figures, Mexico, Doug's birthmarks, Sasha & Naomi, the AEW Jokers, stunt granny mentality, New Era Pro Wrestling, Takeshita Konosuke, and Doug recites his favorite wrestling promo from the previous week! This and all episodes moving forward are now a part of the CPP For Peace & Prosperity Network. CPPFPAPN, is a new telecommunications group that will bring forth the next great reset. Thanks CPP For Peace & Prosperity Network, being the beacon on the hill and the light in our souls. Here are a couple of questions for you after listening: What sister podcast are you most looking forward to listening to? Who would you rather kiss, Vampiro or Konnan? What other promos should Doug act out? My answers: Well since I host “The Joys of Serfdom” I would like to say that one. I suppose Konnan. I would like Doug to do every vignette from the Cactus Jack Lost in Cleveland storyline. Links from the Podcast- Google Sheet of Assignments of the Past  It's All Pro Wrestling Playlist Assignments For Next Week- March 29, 1987- Wrestlemania III: Intercontinental Championship Match- Randy Savage (c.) v. Ricky Steamboat WWE Network/Peacock April 14, 2019- WWE When Worlds Collide- Harper v. Dominik Dijakovic WWE Network/Peacock Check Everything Else We Do: Twitter Instagram Facebooks Merch- Threadless Store Merch- RedBubble Website Songs Used In The Podcast: Intro/Outro- “IAPW Theme?” by Pop-A-Weasel  “Midnight, The Stars and You” by Al Bowlly, Ray Noble & His Orchestra on The Shining Motion Picture Soundtrack “Slaughterhouse” by Powermad, on Absolute Power “Blue Blood” by Heinz Kiessling, on It's Always Sunny in Philadelphia Television Soundtrack “Sing Along” by Sturgill Simpson, on Sound & Fury “Mind Heist” by Zack Hemsey, on Mind Heist

Elon Musk has been accused of sexual harassment by a woman. Musk said to have her identify a part of his body that is strange and only people who have seen his whole body would know. Roger Friedman Interview, Roger has seen the new John Lennon new documentary and says it has a ton of never seen items

Folks we can not continue to allow big money to buy these elections. We must show up in droves to take the country back. It is not a Democrat vs Republican it rather is The Establishment vs We the People.

"Local Folks All Know That Falun Dafa Is Good" by a Falun Dafa practitioner in China. An experience sharing article from the 18th China Fahui on the Minghui website.

Folks still complaining about the NIL? They're only mad that the status quo has changed & they have more work to do.   Yes I am looking at you, Nick Saban, & a TON of media personalities agreeing with him...

Sure the White Sox have been far from great but Chuck Garfien reminds us that it's May and the Twins lead is not that big. 

Matilda von Gierke ist Gründerin und Geschäftsführerin von Zalvus, einer stark wachsenden Unternehmensberatung für zeitgemäße Recruiting-Lösungen. Nach dem Studium war Matilda unter anderem im HR-Advisory und im traditionellen Headhunting tätig. Heute hat ihr 2015 gegründetes, cashflow-finanziertes Unternehmen mehr als 60 Mitarbeitende und zählt bereits ein Drittel aller DAX-Konzerne und 400 KMU aus Europa und den USA zum Kund:innenstamm.

LOOK OUT! It's only Films To Be Buried With!Join your host Brett Goldstein as he talks life, death, love and the universe with show favourite and hilarious comic NISH KUMAR! PART 2!Folks, it's Nish time again! (and again as this is part 2!). OH MY you are lucky as this is the second of an ultramagnetic and super awesome two parter as Brett and Nish go back into the VERY recent past and recount the year in films. Last year, that is. 2021. Just in time. Anyway, time parameters acknowledged, it's a fantastic one with revelations, re-evaluations and revisions having had a little distance from the time, and as such it makes for a perfect time delay - so join in and enjoy the Brett and Nish show, it's a hell of a ride. You shall enjoy!NISH ONLINETWITTERNISH's 'THE MASH REPORT'NISH GIGSBRETT GOLDSTEIN on TWITTERBRETT GOLDSTEIN on INSTAGRAMBRETT GOLDSTEIN on PATREONTED LASSOSOULMATESSUPERBOB (Brett's 2015 feature film)CORNERBOYS with BRETT & SCROOBIUS PIPDISTRACTION PIECES NETWORK on FACEBOOKDISTRACTION PIECES NETWORK on INSTAGRAMSupport this show http://supporter.acast.com/filmstobeburiedwith. See acast.com/privacy for privacy and opt-out information.

This week on Toilet Radio: The metal community lost an absolute titan of the scene this week and we wanted to spend some time remembering our friend. But I promise this episode isn't all tears, we'll also get into the fun, stupid things (we assume) you want to hear. Including: Dismember personally killing Maryland Deathfest forever in a convoluted attempt to avoid the Fauci Ouchie. Looks like Sweden ain't such hot shit now! ROCK N ROLL CORNER. We then take a look at the latest trend that's no good: cancel-culture-themed albums from Polish legacy bands. MOVIE CORNER FEAT. ROBERT ZOMBIE AND CHRISTOPHER GUEST. Finally, The Nuge wants to crack your skull open. BRB getting a come and take it tattoo on my forehead. Folks, it's a podcast. Music featured on this ‘sode: The Black Dahlia Murder – Sunless Empire Don't forget to rate, review, and subscribe to Toilet Radio on iTunes so you'll get new episodes automatically. Or use Stitcher if you don't fuck with Apple.  

Host Mr. Tony Fleming pulls a book off the bookshelf (floor in this episode); "If You Think You Can! by TJ Hoisington".

High Inflation Continues To Impact Sector, Including Food Banks As inflationary pressures keep year-over-year price increases high, food banks see both an increase in demand and a shortage of supply. Food pantries across the country are dealing both with an increase in demand due to broader consumer-facing prices, as well as a harder time keeping up with supply because of the same price increases. The Chronicle of Philanthropy reports that “Some of Feeding America's food pantry partners have closed because of dwindling donations and higher costs for receiving and delivering food. Others have less food on their shelves even though they have higher demand.” The article goes on to highlight the vital importance that food banks serve and that folks who need the assistance they provide might be more diverse than the broader public realizes. Read more ➝   Summary Nonprofits on Both Sides of Abortion Issue See Increase in Donations | The Chronicle of Philanthropy  Independent Sector Issues Statement on Mass Shooting in Buffalo The Guggenheim Museum, Which Long Resisted Calls to Drop the Sackler Name, Has Finally Quietly Removed It | Artnet News HFPA Considers Selling Assets, Dropping Nonprofit Status | Yahoo Entertainment Oregon nonprofit that turns trash into art lands permanent display at the Smithsonian | KGW.com      Transcript [00:00:00] This week on the nonprofit newsfeed, we're talking about high inflation and how it's having impacts on food banks, as well as a bevy of other social impact issues. Nick, how is. [00:00:12] It's going good, George. [00:00:13] it's just trying to, always just trying to keep up last week was a little weird from the financial side. I'm glad we're not a financial podcast, but a few things went sideways and you know, I think that comes back to the larger issue of inflation going on. [00:00:27] That is. Great segue into our first story that is talking about some of those broader trends, economic trends that you were talking about. Namely inflation and our lead story comes from the Chronicle philanthropy, which is supporting that hi Felician is continuing to impact many nonprofits, but food banks in particular. [00:00:50] And it turns out that many food banks across the United States are being. From both directions, essentially, you have more people needing food assistance because of higher food prices and food banks, having trouble keeping up with that higher demand because of higher food and supply chain issues. So. [00:01:14] Yeah, lots of food banks are feeling the pinch, both with supply and demand, kind of impacting their ability to, to provide for, for folks. The article goes on to state that some of feeding America's food pantry partners have closed because of dwindling donations and higher costs for receiving and delivering food. [00:01:34] Others have less food on their shelves, even though they have higher demand. So you kind of have the economics of this. Hitting where Hertz in both directions. And unfortunately the inflation numbers came out and it slowed marginally with the most recent data. But inflation continues to be a really serious problem heading in this case, food pantries, where it hurts. [00:01:56] I think it's important to note that the general consumer price index CPI is it's not accurate for everyone. It is not inclusive of what might be hitting. Some people that are maybe more dependent on travel by car or at the grocery store for different types of materials. But the high-level here. [00:02:19] Compared to last year at this time, we're about 50% down and where we have received and past feral food donations, and about 20% down from food drives in our collection of food from the grocery store, says the executive director, Tyra Jackson there. And it's it. It's tough. It is tough because you're also talking about donations that may have come and picked up by truck by car. [00:02:43] And there are a few donations being. In addition to people needing it more. So, you know, you're going to see this certainly at food, food pantries among others, but something that we really wanted to pull out as a, as a major, a major narrative as only gonna continue as as inflation and gas prices continue to, to pinch organizations that serve the most vulnerable in our. [00:03:06] Yeah, George, I think that's a great analysis. And just as an aside, I was talking with a colleague at our company who she and her partner volunteered at a food bank down in the Nashville area. And. When they were volunteering there, they found out that the food bank was actually closing two weeks later and that all of those resources were disappearing. [00:03:28] So this is very real. This is being felt tangibly by a lot of people. Unfortunately, the most vulnerable people and just calling out to an article. Or featured on this podcast almost a year ago now, but when you look at the statistics of folks on food stamps or folks needing food assistance, it is much more broad and diverse than I think a lot of Americans realize, and that food insecurity is a much bigger and. [00:04:00] Yeah, I'm a much bigger problem than I think most people realize. So it's something we'll continue to follow. [00:04:06] Great. Should we move into our summer yard? Yeah. [00:04:10] Let's do it. Our first article from the summary comes again from the Chronicle of philanthropy. And this is that nonprofits on both sides of the abortion issue are seeing an increase in donations. This was something that we predicted. It's not that hard, a prediction to make. Something we've talked about would happen a couple of weeks ago, of course, with the draft Supreme court decision propelling Roe vs. [00:04:37] Wade. And at this point How the Supreme court is poised to strike that down, back into the forefront of the narrative here. And there are so many organizations on both sides of this issue, local organizations, national organizations, and this is now the most important or most salient, I should say, policy debate in America right now. [00:05:02] So no surprise that non-profits are seeing an increase in donations. It will be interesting to see. How long this lasts. We often talk about how giving because of various news events and attention to these issues have very short life cycles. We talked about donations to Afghanistan, which lasted, everyone was talking about Afghanistan for about 10 days and then nothing. [00:05:30] Right. So it'd be interesting to see here. Especially as it relates to broader kind of political narratives in the United States. The one difference with this is that that decision from the Supreme court has actually not been officially dropped down yet. It's expected to be released in June. [00:05:48] So that, that news cycle we'll get another bump in June when it eventually does drop. But what's your take on the story? [00:05:55] Yeah, it's kind of hard because we're still just sort of pulling in this article at anecdotal evidence and narratives, large narratives like planned parenthood, Federation of America, talking about how. , spokesperson, they're saying they got 70,000, 70,000 new supporters that had signed on with the organization either as donors or volunteers and had received tens of thousands of new one-time gifts. [00:06:21] And the thinking is that if Roe is overturned, the organization's base of supporters are only going to continue to grow and counter narratives there. Pro-life across America, probably of. Groups has not seen a rise in donations since the week, but other smaller ones have said, there's a couple extra thousand here or there coming in. [00:06:40] So still, , I, I, I'm hesitant to draw a macro narratives other than to say, there's going to be an increase amount of volume here. I think this is the first sort of earthquake social earthquake. This announcement ripples are starting to be felt, but I think the big ones still to come. Potential actual decision would be landing. [00:07:01] That would be the summer. Right? Nick, you know, I, I don't know why July is in my mind, but [00:07:05] Yeah, I think end of June a lot has something to do with the docket. Yeah, [00:07:11] so we'll see. But within the next one to two months, general, [00:07:16] I would say from a strategy standpoint, this was the first press it, but the, the wave of. News and attention is going to be very, very intense. And as all things intense, it will burn brightly and briefly, unfortunately, and then come down to that steady drum beat. So you are an organization that is near or adjacent to this topic. [00:07:38] I would be very much prepared for how you pull in. Monthly sustaining donors in that moment of emotion when emotions are at its peak, because the work is going to take quite some time and it's not a one and done it is something that should it should be part of a, a longer term movement that is is going to take a lot of resources. [00:08:01] Absolutely. That's a great framing. I for one I'm done with earthquakes for, for another decade, no more society altering earthquakes. But unfortunately we have another one. To talk about. And we're framing this around a press release from independent sector, which is a national membership organization that brings together nonprofits and foundations and corporate giving partners. [00:08:28] But they put out a press release, acknowledging the violence in Buffalo over the weekend. That being that over the weekend, a white supremacist went into a supermarket in Buffalo, New York shot. 13 people, 11 of whom were black and 10 of whom died. This was an over act of racism and white supremacy was very, very clear. [00:08:52] And We see the nonprofit community responding here. I don't really know. What more to what non-profits can can do about this. This is, this is hard, a hard, very hard problem to solve. And of course, there's lots of organizations that work in this space, the Southern poverty law center and civil rights organizations that of course over the past couple of days have been really highlighting how national political discourses lending itself to this, these far right ideologies and extremist ideologies. [00:09:25] But Yeah, just unfortunately, and another tragic day in a long string of mass shootings that we experienced in this country. [00:09:32] We saw the narrative, certainly of gun rights and organizations like our town saying reasonable things. Like, I dunno, maybe we shouldn't allow citizens to run around with assault rifles , these high capacity magazines and the ability to, to do that much damage in that period of time, there was another narrative around. [00:09:51] How this was actually streamed on Twitch, which can lead to copycats and narratives that this shooter was partially inspired by Christ church shooting, which was also incredibly terrible, but this sort of mimicry of when people see it is a, a dog whistle and just very dark motivation for, for certain people that clearly need help. [00:10:14] Like this is somebody who needs. Folks that are, , drawn to this type of thought, unfortunately, and this type of action then there's a new piece that seemed to be coming out, which I I'm starting to see nonprofits touch on, which is the narrative around replacement theory. And I'm not going to go into it in so much as, you know, giving it any sort of, even the word theory there it is. [00:10:39] It is a white supremacist fever dream, and I don't curse on this podcast, but I would, if I could, because it's it's a narrative that is unfortunately use because it's pulled into media narratives and reiterated on shows like Tucker Carlson, but it has a very, very dark and dangerous, extreme narrative to it. [00:11:02] And so there may be opportunities for if this does touch on a non-profits work in association with. You know, immigration, anything that supports black or brown people and their rights in this country to, take a look at it and see where your voice on it could, could lend a larger and more clarifying narratives on it. [00:11:25] Absolutely George. I couldn't agree more. And quite frankly, I want to see tech companies take a far more aggressive stance on combating this quite frankly. It's unacceptable. The video was five streamed and is just it's. So you type it into Google. It's the first thing you see that is unacceptable. And I would love to see greater efforts behalf of big tech to work with nonprofits and civil society to, to attempt to mitigate this. [00:11:58] Because quite frankly, it's the pervasiveness of these kind of fringe ideas. And I know that's a whole other thing, but I think that there can be a lot more done. And I think that nonprofits and civil society should be invited to play a role in. [00:12:13] Yeah. I don't know what the right answer is. I get worried sometimes about. The narratives that take hold and whether or not it's used as an excuse to go after big tech. The truth is Twitch took that down within two minutes, which is a heck of a lot more impressive in terms of a timeframe than what Facebook did. [00:12:32] A company, 10 X its size with Facebook live. The truth is the ability to publish on the web. Can't be fully blocked. And by saying like, if only it was taken down, what in thirties. If only it was taken down in 10 seconds, I just don't understand the channeling of the social solution. Can't be a faster form of censorship. [00:12:56] Would've stopped this. I'm not, I'm not buying that as a solution, giving that child that 18 year old, maybe not access to a assault rifle. Would be maybe where I start followed by again, pointing toward being very careful when someone's consuming certain types of content in an extreme environment. And also this individual was given access to body armor. [00:13:26] And so the whole narrative of good guy with a gun didn't matter because this person was actually shot at. And it didn't matter because we have turned extremists into super soldiers with over the counter shit. You can get it well, So I, I'm sorry, I'm not buying if only Twitch took it down and got Dan two minutes, I'm not, I'm not buying that sale. [00:13:45] That's fair. That's a fair, that's a fair argument. I agree with you the much more. Proactive way of dealing with this is a gun laws in New York actually has this red flag gun law that should have prevented the shooter from accessing this firearm. And for whatever reason, [00:14:02] Yeah, I haven't seen the full near, I mean, just, I haven't seen the full narrative, but you know, there's more, there's more guns and people in this country. So I don't know. [00:14:10] I agree. Our thoughts are with the families and everyone affected by, by this fine. Our next story comes from news.art net.com. And this is about the Guggenheim museum, which has long resisted calls to drop the Sackler name, the Sackler family, being the family owners of the Purdue pharma corporation has finally quietly removed the Sackler name from. From the building, the Guggenheim has come under lots of criticism and there's been sit in protests at the museum and attempt to bring to light how this family's money is, is as you know. [00:14:53] highlighted throughout this museum as a donor. [00:14:56] And yeah, George authored this to you. I think I have. Complicated FOBTs here and being a new Yorker, we're both new Yorkers. You walk through any museum, the Guggenheim, the met every exhibit is a who's who of corporate power in America, half the ma is named after the Koch brothers. You know? So it's yeah, I wonder what your take is on this. [00:15:21] It's kind of dovetails a bit also with when we were talking about how. Russian oligarchs were giving in the west to legitimize and cause wash disreputable actions and reputation, and to build themselves up, the nonprofit industry does offer this sort of pathway to respectability at a price. And the question is. [00:15:48] Is it appropriately priced? Should that be for sale? I think this is a big move because clearly the Sackler name like has donated quite a bit to, to the arts and the arts are incredibly important, but maybe not as important as the fact that what they have done to. Drug addiction. And this country is probably unparalleled from other companies in terms of it's devastation. [00:16:20] And , maybe you don't give them the social acceptance pass, but hopefully this is something that reverberates out there that it's also hard. If you're an art, I try to put on the other side of it, like there's somebody on the fundraising team of a struggling museum trying to preserve. [00:16:37] You know, history and legacy of fill in the blank type of art that already struggles. And to say like, oh, you're not allowed to take, you know, money from somebody who that happened to make it from oil from this. So like, you know, where do you draw the line? I mean, I draw the line there, the Sacklers, but you know, it is, it makes, it makes for an interesting conversation, I think in philanthropic communities and maybe even. [00:17:02] Just to bring it back to a listener right now you might want to have with, you know, your board and your supporters being like, you know, who would we not take money from if we did Y what would we do? You know, I think there's a lot of folks that take it and be like, oh, you can make a donation, but sorry, we can't name you. [00:17:18] Like, what did you just do? They're like, all right, we're, we're playing this weird sort of moral shell game. [00:17:25] Yeah, I think that's as an interesting analysis and to your point, I would not want to be the fundraiser I'm responsible for that, but definitely something to talk about. Within your organization. Another organization that's been doing a lot of talking within itself is the Hollywood foreign press association, which you may know as the obscure organization that is responsible for hosting and promoting the golden Globes in Hollywood. [00:17:55] So the Hollywood foreign press has been criticized pretty substantially in the past couple of years for. And I think rightly so and incredible lack of diversity kind of opaque voting processes. And as it turns out this organization, which is a nonprofit actually is reincorporating itself as essentially a business they're selling off assets, they're going to drop their nonprofit status and attempt to boost the golden Globes As a ceremony, I guess. [00:18:29] I'm not as well versed in pop culture as nearly anyone, but it's kind of an interesting move. [00:18:38] Yeah, I don't know. I thought it was just funny that it didn't even Dawn on me that the Hollywood foreign press association was a nonprofit. There are a lot of non-profits out there operating for, for better or worse or for interesting. And I'm always curious when there's a transition, either from a non-profit to for-profit for-profit to nonprofit. [00:18:57] I tend to see this a lot less, the, the move. And I just curious to watch what the net effect is. If anything interesting comes of it, you know, we'll bring it up, but you know, good luck. Sorry. You're leading the team. Am I. [00:19:12] I. [00:19:13] don't know if it gets us. Ricky Jervais is one more year of cringe-worthy. Self-loathing Hollywood criticism all sign up for that highlight reel. [00:19:24] Yeah. As long as, you know, I feel maybe touch better that any profit they happen to be making off of that particular spectacle isn't tax tax subsidized [00:19:34] Hmm. [00:19:35] touch better. [00:19:35] There you go. All right. How about a feel-good story, George? [00:19:39] Sounds perfect. [00:19:41] All right. This is from a local NBC affiliate. K G w. Dot com out of Oregon and it talks about an Oregon nonprofit that's on a mission to bring awareness to plastic pollution by turning trash into treasure and has landed a permanent display at the Smithsonian museum of natural history in a. [00:20:04] Washington DC. And essentially they've processed 37,000 tons of plastic from Oregon's beaches. And they've created 87 works of art and the art as looking at some of the pictures kind of like wide ranging implications. But the, or vision it's a wide vision. But it seems to me that you're keeping trash out of the ocean and creating something beautiful. [00:20:31] Sounds like a winning company. [00:20:33] I look at this just incredibly creative to take the exact problem that is destroying sea life and turn it into incredible works of art, which then forced people to, to see this. And, you know, there's this beautiful picture of a turtle created by all of the plastic junk and it just hits you so tangibly to see something at one striking beautiful something you'd associate with nature, but then realize that that that is exactly. [00:21:03] These animals are consuming in the wild increasing amounts of plastic, which have a devastating, devastating impact on ecosystem could be ideas also, as you work on various issues of how do I take the thing that is the biggest threat and turn it into the medium of awareness. And there's something beautiful about this. [00:21:24] I love it. Thanks George. [00:21:27] Thanks Nick.  

Folks do not want to miss this great discussion on all things presuppositional. Enjoy this fun and informative roundtable discussion.

This week Chris and Miss Kay welcome in Alan Johnson to talk about the upcoming North event on Wheeler Lake, one of, if not the hottest lake in Alabama right now. Then Lay Lake Champs Chris Rutland and Coby Carden join in to talk about their recent win and then ABT Superfan, Alan Anthony jumps in to walk about who's in and who's out in the ABT South Division pointw when they head to Eufaula next month. Man what a show!

WHY MEN STRUGGLE TO LOVE  DR. EDDIE CAPPARUCCI PT 2 Dr. Eddie Capparucci is a licensed professional counselor and certified coach. He also is certified in the treatment of Problematic Sexual Behaviors and is the creator of the Inner Child Model for the treatment of sexual and pornography addiction. Among his many clients, Dr. Capparucci has worked with professional athletes including NFL and MLB players and television personalities. He serves as the clinical director for the National Decency Coalition, an organization working with state governments to help limit the access of pornography to minors. His ministry is “Abundant Life Counseling” located in Highlands, NC. He is the author of several books, including https://amzn.to/3MyALRd (“Going Deeper: How the Inner Child Impacts Your Sexual Addiction;”)https://amzn.to/3MtCB5Q (“Removing Your Shame Label: Learning to Break Free of Shame and Feel God's Love”) and his most recent book, https://amzn.to/3EN9APF (“Why Men Struggle to Love: Overcoming Relational Blind Spots.”) You've identified 9 inner child symptoms and core emotional triggers. Can you share some of them with us? Explain the term “Emotional Intimacy” and how that relates to sexual addictions or porn addictions… But if someone is in a committed relationship, marriage, etc., aren't they emotionally bonded, to use your term from the book, to their partner? Your most recent book, https://amzn.to/3EN9APF (“Why Men Struggle to Love: Overcoming Relational Blind Spots,”) why do you believe this book is so needful at this point in our culture today? The title of your book is, https://amzn.to/3EN9APF (“Why Men Struggle to Love,”) so, I guess the question I need to ask is, “Why do men struggle to love?” Is it true that some of this relates back to things that happened in their childhood? Or is that just a popular fallacy? In your book, https://amzn.to/3EN9APF (“Why Men Struggle to Love,”) you state your mission is not to “rid men of their destructive behaviors, but instead, to transform their hearts.”  Can you explain how that will help them gain victory over their sexual addictions? With the current internet generation, porn is so accessible as compared to when I was growing up. You used to have to the “five and dime” store and then stand in the aisle and try and look at the girlie magazines without drawing attention.  It's not like that today. Just about anyone and any age can access things that, just can't be described, it's so bad…  How can we avoid all that we are faced with? Can you briefly go over some of the 14 “Blind Spots” men need to overcome in order to emotionally connect to their spouse, significant other, etc., as outlined in your book? What could the consequences be if men fail to connect or emotionally bond with others? Now, this next question can be twisted to mean different things and that is not my intention. But there are many women who dress, let's just say, seductively, on purpose. I know we are focusing here on men struggling with sexual addictions, but what are your thoughts on someone of the opposite sex that strive to plant those thoughts in the minds of men? Do they have some underlying problems similar to the ones you are sharing about men and their sexual addictions? Dr. Capparucci, this is all so interesting – and so needful – in the culture we are living in today. How can someone order a copy of your book, https://amzn.to/3EN9APF (“Why Men Struggle to Love: Overcoming Relational Blind Spots?)” Is it available on Amazon? If someone wanted to get in touch with you, to ask a question, to seek your services or a referral to someone near them or maybe possibly do an interview such as this, how can they do that? How can someone get in touch with you? I'll put all of this down in the show notes below. Folks, especially you men out there, admit it. You've seen yourself in some of the things Dr. Capparucci has been discussing today. I know I've seen...

What is a digital mindset? Why is it important? And can non-technical people really contribute in digital roles? In this week's episode of The Mind Tools L&D Podcast, Ross D and Ross G explore these questions with researcher, consultant and author of Digital Mindset, Dr Paul Leonardi. We discuss: How anyone can adopt a digital mindset The importance of collaboration, computation and change How much you need to know to ‘sniff test' statistical claims. The Digital Mindset: What It Really Takes to Thrive in the Age of Data, Algorithms, and AI, by Paul Leonardi and Tsedal Neeley, is available now. In 'What I Learned This Week', Ross D shared a tweet from Adam Grant: twitter.com/AdamMGrant/status/1523656067838021632 Ross G shared the paper: Brucks, M. S., & Levav, J. (2022). Virtual communication curbs creative idea generation. Nature, 1-5. Available online at: nature.com/articles/s41586-022-04643-y Paul discussed the paper: Shih, K. (2017). Do international students crowd-out or cross-subsidize Americans in higher education?. Journal of Public Economics, 156, 170-184. Available online at: sciencedirect.com/science/article/abs/pii/S0047272717301676  For more from us, including access to our back catalogue of podcasts, visit mindtoolsbusiness.com. There, you'll also find details of our award-winning performance support toolkit, our off-the-shelf e-learning, and our custom work. You can find out more about Paul at: tmp.ucsb.edu/people/paul-leonardi Find out more about Tsedal Neeley at: tsedal.com Connect with our speakers If you'd like to share your thoughts on this episode, connect with our speakers on Twitter: Ross G - @RossGarnerMT Ross D - @RossDickieMT Paul Leonardi - @PLeonardi1

On today's program, from Brazil, we have Dr. Esly Carvalho who is going to share with us the negative effects of sexual abuse and other traumas, our coping mechanisms, as well as some of the "ways of escape" that God has provided through EMDR and other therapies. 

Folks we're back to finish what we started…  In last week's Bonusisode we featured Part One of Tax Planning Tips to Maximise your Returns and now, we're back to give you the rest of the gold!   We'll be unpacking…  [...] CONTINUE READING The post Bonusisode with Julia – Tax Planning Tips to Maximise your Returns (Part Two) appeared first on The Property Couch.

Why Men Struggle to Love Dr. Eddie Capparucci pt 1 Dr. Eddie Capparucci is a licensed professional counselor and certified coach. He also is certified in the treatment of Problematic Sexual Behaviors and is the creator of the Inner Child Model for the treatment of sexual and pornography addiction. Among his many clients, Dr. Capparucci has worked with professional athletes including NFL and MLB players and television personalities. He serves as the clinical director for the National Decency Coalition, an organization working with state governments to help limit the access of pornography to minors. His ministry is “Abundant Life Counseling” located in Highlands, NC.  He is the author of several books, including https://amzn.to/3MyALRd (“Going Deeper: How the Inner Child Impacts Your Sexual Addiction;”)https://amzn.to/3MtCB5Q (“Removing Your Shame Label: Learning to Break Free of Shame and Feel God's Love”) and his most recent book, https://amzn.to/3EN9APF (“Why Men Struggle to Love: Overcoming Relational Blind Spots.”) Help me welcome to the program, Dr. Eddie Capparucci. First question, other than that brief information I just shared, can you tell us in your own words, “Who is Eddie Capparucci?” Your wife is responsible for leading you, ultimately to the Lord, right? With your background in the corporate world, how did you get involved in helping to set men free from sexual addictions? You have, more or less, coined the term, “Getting rid of porn addiction by healing the inner child.”  Can you tell us a bit about what that term actually means? You've identified 9 inner child symptoms and core emotional triggers. Can you share some of them with us? Explain the term “Emotional Intimacy” and how that relates to sexual addictions or porn addictions… Folks, especially you men out there, admit it. You've seen yourself in some of the things Dr. Capparucci has been discussing today. I know I've seen myself in some of these things. It's there. It needs to be dealt with. God's Word is there for you. All deliverance is in and through God's Word. But, many, many people, especially men, need the extra help to overcome these types of addictions. I urge you, first, order a copy of Dr. Eddie Capparucci's book https://amzn.to/3EN9APF (“Why Men Struggle to Love: Overcoming Relational Blind Spots.” ) Drop down into the show notes and click the link right there. Do so now, while you are thinking about it. Don't listen to the devil telling you to wait until later. You know as well as I do that you'll end up doing nothing at all. Act now!  God has brought Dr. Capparucci onto this program today, to speak to you right now. If that's you – order his book right now. Amen! CONTACT INFORMATION: https://amzn.to/3EN9APF ()Email:   edcappa@gmail.com Website: https://www.strugglingmen.org/ (https://www.strugglingmen.org) Book:  https://amzn.to/3EN9APF (“Why Men Struggle to Love: Overcoming Relational Blind Spots”) on Amazon  Other Books by Dr. Eddie Capparucci on Amazon: https://amzn.to/3MyALRd (“Going Deeper: How the Inner Child Impacts Your Sexual Addiction;”) https://amzn.to/3MtCB5Q (“Removing Your Shame Label: Learning to Break Free of Shame and Feel God's Love”)

Huge milestone for us, 350 Episodes of our show! In the last year, we've had some amazing guests on the show. Folks like Phil Joel from the Newsboys, Dr. Gary Chapman, Carey Nieuwhof, Gabe Lyons, Alex Kendrick, Will Doggett, Lee Strobel, Dennis Worley, William Vanderbloemen and dozens of other incredible guests. We've talked about production, worship leading, staffing trends and culture, songwriting, church websites, changing your ‘church online' game and more. We're having so much fun. And we're not slowing down! This week, our guest is former Elevation Church Worship Leader Wade Joye. Wade Joye served as the Worship Pastor at Elevation Church under the leadership of Pastor Steven Furtick for over 14 years until transitioning off of staff in late 2021 to serve churches across the country through his teaching and coaching ministry. During his time at Elevation, Wade oversaw the development of worship culture and staffing for over 20 locations, and spearheaded the growth and pastoring of Elevation Worship. In addition to building worship culture across all Elevation locations, Wade was instrumental in creating the systems that allowed Elevation Worship songs to go around the world as he led the record label and touring teams. He brings a wealth of knowledge and experience to the topics of Worship Leading, leadership, culture and more. We're very excited to welcome Wade Joye. SHOW NOTES --- Support this podcast: https://anchor.fm/makingsundayhappen/support

Folks, on this week's What A Time To Be Alive we hear about the world's most boring playground, why sea turtles have no idea where they're going, why a wrestling death match in Britain shocked a small town, why James Cromwell glued himself to a Starbucks counter, and why South Koreans are changing everyone's age by one year We're doing another live show this July 8th at the Gutter in Greenpoint, Brooklyn! Tickets available now! (Are you a patron? Check the Patreon for discounted tickets! Or join right now and get the discount!) https://www.eventbrite.com/e/what-a-time-to-be-alive-live-at-the-gutter-tickets-337420623167 We are on Patreon! Become a patron for weekly bonus eps and more stuff!: www.patreon.com/whatatimepod Check out our YouTube channel: https://www.youtube.com/c/whatatimetobealive Get one of our t-shirts, or other merch, using this link! https://whatatimepod.bigcartel.com/ whatatimepod.com J oin our Discord chat here: discord.gg/jx7rB7J @pattymo // @kathbarbadoro // @eliyudin // @whatatimepod © 2022 What A Time LLC

Welcome Folks, Fam, Revs, & new initiates,Comics are widely heralded as a wonderful art form; for kids! Yet, so many of us grown individuals find them to be more than just amusing. They are a history lesson, future promise if change is not made, multitudinous story that travels across the many different universes; and courses like blood in our veins pulsing our very being. They are box paneled tidbits of life with a new vision once a month, or maybe you enjoy taking them in the most novel sense; graphic at heart.Cool Stuff Man managed to find a break from the superheroe preparatory comic training school to teach us posers, the ins and outs of Comic book lore. We discuss the societal messages portrayed in the pages of these books, and their ability to evoke thought by dramatizing real life. The engrossing nature of life depicting art while embarking on the ultimate question: "What if?"  Once a fearful existence, now we are embraced - modeled - emulated - and cos-played; we are free to show our true selves and the beauty that is the diversity of Comickazes. Take caution as you embark as this landing will be quite the impact, as we embark upon the ideas behind the ink.Thank you to  Cool Stuff Man @cool_stuffman it was a pleasure to see and speak to you unmasked. Promise your secret identity is safe with Free Thought Revolution- Interactive Artistic Podcast. Thank you for the introductory wisdom JD Banks @blackbearcatpress always a strong firile lead if we are to be successful. Thank you @asett_auco for amplifying the voices and ensuring we stay on meme #HUmanizeUs.Folks, Fam, Revs, & new initiates, be blessed and thank you for the privilege to share these voices, energy, and this space with you. Community only grows if we nurture the seeds of life.Thoughts are free, Revolution takes action; Be Revolutionary!Support the show

Katie Holmes in a lazy southern accent asks, “What's the matter? See somethin' bad?” and we are immediately transported back to the year 2000 when the trailers for this movie were EVERYWHERE.  Writer and podcasting icon Starlee Kine joins us to talk about Sam Raimi's “The Gift” - a film with an incredibly stacked cast of actors who were eager to sink their teeth into a Southern Gothic Billy Bob Thornton creation. Do we buy Keanu as a wife-beating redneck? Is Cate Blanchett actually a terrible psychic? How does Giovanni Ribisi's performance in this rank among his most deranged screen outings? Folks - we apologize in advance for bringing up “The Other Sister”. This episode is sponsored by: Shopify (shopify.com/check) Indeed (indeed.com/check) Bombas (bombas.com/check) Join our Patreon at patreon.com/blankcheck Follow us @blankcheckpod on Twitter and Instagram! Buy some real nerdy merch at shopblankcheckpod.myshopify.com

Folks we have 5 Game 7s in the NHL this weekend. Five. While I wish the Rangers had already advanced by now I will give my thoughts on the matchups and who should move on to the next round.

The GLUE of Leadership Development Amy Kelly pt 1 https://amzn.to/3Pf9plk ()Have you ever had a workplace disagreement in your career?  It may not have even been that bad of a disagreement. But over time, it continued to eat away until, ultimately, it DID affect your life, your workplace, your family, etc.? Have you ever said something that you regretted saying? Have you ever done something that had the opposite effect you intended and you wished you could go back and do over in a different way? Making decisions in business and in relationships is normal. How you communicate and how you handle decisions can result in either success or failure. Each decision you make can either strengthen the bonds of the relationships you have – or tear them apart. Sometimes, when you handle things the wrong way and the relationship is torn apart, you wish there was some type of glue to bring it all back together, right? Well, my guest today just happens to have that glue available for you to use… Amy Kelly is the Vice President of Consulting for the Jon Gordon Companies and a human resource and talent development executive who is known for building high-performance talent and cultures, including award winning workplaces and leadership development programs. She has released a book titled, https://amzn.to/3Pf9plk (“G.L.U.E. – A Leadership Development Strategy to Bond and Unite.”)  This book is a must read for any business, any home, any community or ministry leader who needs to grow personal leadership effectiveness and create unity in the home, workplace and world. How does this fit into the discussion of minimizing disagreements and negative emotional energy that you describe? How did the COVID pandemic, shutdowns and all of that effect what you are trying to share in this book? Does this book, https://amzn.to/3Pf9plk (“GLUE”) help to create the same type of environment in the home as well as the workplace? How can someone who may be deeply involved in community projects use these precepts to rally support for the cause while still allowing personal and professional growth of those involved that may not always involve the organization? If you could sum up in one statement what the main takeaway your readers will have from this book, what would that be? How can someone obtain a copy of your book, https://amzn.to/3Pf9plk (“G.L.U.E. – A Leadership Development Strategy to Bond and Unite,”) is it available on Amazon? Amy, this is so interesting. If someone has a question, how can they get in touch with you or obtain more information? I'll put links to all of this down in the show notes below… Folks, you need to obtain your own copy of Amy Kelly's book, https://amzn.to/3Pf9plk (“G.L.U.E. – A Leadership Development Strategy to Bond and Unite.”) This book will transform your life, your business and your relationships. Just go down into the show notes and click the links right there to order your copy today. CONTACT INFORMATION: https://amzn.to/3Pf9plk ()   Email:  amypkelly@leadership.com Website:  http://www.gluebondandunite.com/ (www.gluebondandunite.com) Book: https://amzn.to/3Pf9plk (“G.L.U.E. – A Leadership Development Strategy to Bond and Unite”) – on Amazon

LOOK OUT! It's only Films To Be Buried With!Join your host Brett Goldstein as he talks life, death, love and the universe with show favourite and hilarious comic NISH KUMAR!Folks, it's Nish time again! OH MY you are lucky as this is the first of an ultramagnetic and super awesome two parter as Brett and Nish go back into the VERY recent past and recount the year in films. Last year, that is. 2021. Just in time. Anyway, time parameters acknowledged, it's a fantastic one with revelations, re-evaluations and revisions having had a little distance from the time, and as such it makes for a perfect time delay - so join in and enjoy the Brett and Nish show, and come back for the second part next week!NISH ONLINETWITTERNISH's 'THE MASH REPORT'NISH GIGSBRETT GOLDSTEIN on TWITTERBRETT GOLDSTEIN on INSTAGRAMBRETT GOLDSTEIN on PATREONTED LASSOSOULMATESSUPERBOB (Brett's 2015 feature film)CORNERBOYS with BRETT & SCROOBIUS PIPDISTRACTION PIECES NETWORK on FACEBOOKDISTRACTION PIECES NETWORK on INSTAGRAMSupport this show http://supporter.acast.com/filmstobeburiedwith. See acast.com/privacy for privacy and opt-out information.

CrossPolitic Daily News Brief for Wednesday May 11th, 2022. Intro this clip: https://twitter.com/johnwesleyreid/status/1524032799501697037 Justice Alito’s neighbor decided to blast “Tis So Sweet To Trust in Jesus” as pro-abortion protestors, outside of Alito’s home, shout something about wanting justice? Have you signed up for our show in Arizona…it is next week, what are you waiting for! Folks- we got some exciting news for the happenings going around here at CrossPolitic and the Fight Laugh Feast Network. First, starting May 30th, CrossPolitic will be moving to a daily show, airing every day at 6pm and of course dropping podcasts. Knox has been pushing us to do this for two years, and he has finally won that argument. So, get ready to tune into you number one nightly news and commentary source! Secondly, to make room for all this new production, the Daily News Brief will be going back to audio, which is where a bulk of our Daily News listeners were at anyways. Thirdly, we have a bunch of new club member benefits we are working on, including an updated website club portal and club only social media platform. So, those listeners who have been lingering in the background, join the club, the party is just getting started. And for our thousands of club members, thank you for staying with us, your continued support, and your prayers. We have a lot of work ahead of us, and this very much feels like a further up and further in moment. Now where was I. Oh that is right, the bloodlust for the abortion crowd is insanity, and you will be seeing unleashed insanity if Roe is overturned. After calling the LGBT to arm themselves, the Mayor of Chicago also promised that Chicago would become and abortion sanctuary. The call of violence is spreading and this pass Sunday a molotov cocktail was thrown into the Wisconsin Family Action offices. As the pro-abortion community found out about it, they decided to leave messages, and here is a compilation of some of those messages: https://notthebee.com/article/pro-life-wisconsin “​​(A) radical pro-abortion group named Jane’s Revenge is saying it was responsible and is threatening increasingly violent attacks that extend beyond Wisconsin if its demands are not met, writing, “Wisconsin is the first flashpoint, but we are all over the US, and we will issue no further warnings.” https://www.lifenews.com/2022/05/10/pro-abortion-group-says-it-firebombed-pro-life-office-promises-more-violence-nationwide-our-last-warning/ Plug Did you know that more than 75% of those raised in evangelical, Presbyterian, and Reformed churches don’t pursue any kind of Christian higher education? Surprising isn’t it. Cornerstone Work & Worldview Institute is seeking to provide a new, exciting, and affordable option for Christians. Their mission is to build Kingdom culture in the workplace by equipping their students in a Trinitarian worldview and vocational competencies. Their low-cost full-time program offers integrative course modules, internships, and mentoring so their students can finish debt-free with vocational preparation, a robust faith, and financial potential to build strong godly families and homes rooted in their communities and churches long-term. Visit their website at www.cornerstonework.org to find out more about enrolling. Elon Musk would let President Trump back on Twitter and cited the ban was "foolish to the extreme”. Roll clip: https://twitter.com/disclosetv/status/1524085282366177283 Friends, we have tons of military personnel that listen to our shows, and they keep us in the loop about what is going on, on the inside as they fight for their careers against the forced vaccination policies. Well right now there is an important court case in front of a federal district court judge in Omaha, that if the judge would rule in favor of religious exemptions, it would apply to the Air Force nationwide. According to the Omaha World Herald: https://omaha.com/news/state-and-regional/offutt-airmen-ask-judge-to-block-covid-vaccine-mandate-citing-religious-beliefs/article_8e96601c-cd89-11ec-b0a7-1f525a4310d5.html “Three current or former Offutt airmen who have refused the COVID-19 vaccine on religious grounds asked a federal district court judge in Omaha on Monday to stop the Air Force from discharging or otherwise punishing them. Capt. Ian McGee, an RC-135 instructor pilot with the Offutt-based 55th Wing, said he applied for a religious exemption eight months ago but hasn’t received a response from his chain of command. He expects it to be denied, as the Air Force has denied nearly all of the more than 7,800 airmen who have applied for them under the Religious Freedom Restoration Act, known as RFRA. McGee said he would give up his nine-year military career rather than be injected with a vaccine tested with cell lines taken many years ago from aborted fetuses. “It goes against my sincerely held religious beliefs as a born-again Christian,” McGee testified. “My resolve is to stay with my relationship with Jesus Christ.” The three airmen are part of a larger group of 36 — including active-duty, National Guard and reserves — who filed suit in U.S. District Court in Nebraska in March seeking to overturn the mandate issued by the Pentagon last August. They argue it is a violation of their First Amendment rights. They are represented by former Kansas Attorney General Kris Kobach and a team of lawyers from the America First Policy Institute, a conservative think tank organized last year by several top advisers in the administration of former President Donald Trump. Kris Kobach “blasted the elaborate multi-level review of the applications for religious exemptions, alleging that more than 7,500 have been denied and only 46 granted. And the ones granted were only for airmen who were within six months of retirement.” Be praying for our people in the military. This is stressful on their families, careers, and the mainstream media is giving them no voice. CrossPolitic is glad to do our part! Meanwhile, the Republican Senate is making some chess moves on behalf of our friends fighting in the military. According to the Military Times: https://www.militarytimes.com/news/coronavirus/2022/05/10/bill-would-mandate-honorable-discharge-for-all-troops-who-refuse-covid-vaccine-mandate/ A “proposal — led by Texas Sen. Ted Cruz and backed by 13 other GOP colleagues” Would require Defense officials “to grant honorable dismissals to nearly all troops who refuse the COVID-19 vaccine and grant waivers to troops with “natural immunity” to the virus under new legislation introduced by Republican senators on Tuesday.” It “would also mandate that military leaders “make every effort to retain members of the Armed Forces who are not vaccinated” and broaden religious exemptions for the vaccine mandate.” Cruz said: ““It is absolutely unacceptable that [President Joe Biden’s] administration is trying to coerce our men and women in uniform to violate their conscience and religious beliefs, let alone on an issue as polarizing as the COVID-19 vaccine.” Last month, defense officials told Congress that about 3,400 troops have been involuntarily separated from service for refusing to get the COVID-19 vaccine, mandated last fall for all military members. Of that group, about 70% have received general discharges, a designation that allows them to receive most veterans benefits and potentially rejoin the military at a later date. The other 30% have received honorable discharges. Congress last year forbade military leaders from issuing dishonorable discharges for vaccine refusal.” Lies, Propaganda, Story Telling, and the Serrated Edge: This year our national conference is in Knoxville, TN October 6th-8th. The theme of this year’s conference is Lies, Propaganda, Storytelling and the Serrated Edge. Satan is the father of lies, and the mother of those lies is a government who has rejected God. We have especially been lied to these last two years, and the COVIDpanic has been one of the central mechanisms that our government has used to lie to us and to grab more power. Because Christians have not been reading their bibles, we are susceptible to lies and weak in our ability to fight these lies. God has given us His word to fight Satan and his lies, and we need to recover all of God’s word, its serrated edge and all. Mark your calendars for October 6th-8th, as we fight, laugh and feast with fellowship, beer and Psalms, our amazing lineup of speakers, hanging with our awesome vendors, meeting new friends, and more. Early bird tickets sale now!. Lastly, and I actually like this play here. DeSantis Signs Bill Requiring High Schools to Observe ‘Victims of Communism Day’ https://www.ntd.com/desantis-signs-bill-requiring-high-schools-to-observe-victims-of-communism-day_776951.html According to the NTD: “Florida Republican Gov. Ron DeSantis signed a bill Monday that requires “Victims of Communism Day” to be observed annually in public high schools across the state. The bill, known as HB 395, requires public schools to tell students about genocides, famines, and persecutions under communist regimes, including the Chinese Communist Party (CCP) and the Soviet Union. The bill passed the Florida House and Senate unanimously earlier this year. “We want to make sure that every year folks in Florida, but particularly our students, will learn about the evils of communism, the dictators that have led communist regimes, and the hundreds of millions of individuals who suffered and continue to suffer under the weight of this discredited ideology,” DeSantis said Monday morning. The Victims of Communism organization has estimated that communist regimes have caused the deaths of at least 100 million people via political purges, religious persecutions, mass starvation, and other crimes against humanity during the 20th century. Chief among those regimes is the CCP, which is believed to have left around 80 million Chinese people dead.” This is Gabriel Rench with Crosspolitic News. Support Rowdy Christian media by joining our club at fightlaughfeast.com, downloading our App, and head to our annual Fight Laugh Feast Events. If this content is helpful to you, would you please consider becoming a Fight Laugh Feast Club Member? We are trying to build a cancel-proof media platform, and we need your help. Join today and get a discount at the Fight Laugh Feast conference in Knoxville, TN and have a great day. Have a great day. Lord bless